Document ID: EPA-HQ-OPPT-2002-0060-0001
Agency: epa
Document Type: Rule
Title: Significant New Uses of Certain Chemical Substances
Posted Date: 2003-03-28T05:00Z

15061
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
interested
in
commenting
must
do
so
at
this
time.

IV.
Statutory
and
Executive
Order
Reviews
A.
General
Requirements
Under
Executive
Order
12866
(
58
FR
51735,
October
4,
1993),
this
action
is
not
a
``
significant
regulatory
action''
and
therefore
is
not
subject
to
review
by
the
Office
of
Management
and
Budget.
For
this
reason,
this
action
is
also
not
subject
to
Executive
Order
13211,
``
Actions
Concerning
Regulations
That
Significantly
Affect
Energy
Supply,
Distribution,
or
Use''
(
66
FR
28355,
May
22,
2001).
This
action
merely
approves
state
law
as
meeting
Federal
requirements
and
imposes
no
additional
requirements
beyond
those
imposed
by
state
law.
Accordingly,
the
Administrator
certifies
that
this
rule
will
not
have
a
significant
economic
impact
on
a
substantial
number
of
small
entities
under
the
Regulatory
Flexibility
Act
(
5
U.
S.
C.
601
et
seq.).
Because
this
rule
approves
pre­
existing
requirements
under
state
law
and
does
not
impose
any
additional
enforceable
duty
beyond
that
required
by
state
law,
it
does
not
contain
any
unfunded
mandate
or
significantly
or
uniquely
affect
small
governments,
as
described
in
the
Unfunded
Mandates
Reform
Act
of
1995
(
Pub.
L.
104
 
4).
This
rule
also
does
not
have
tribal
implications
because
it
will
not
have
a
substantial
direct
effect
on
one
or
more
Indian
tribes,
on
the
relationship
between
the
Federal
Government
and
Indian
tribes,
or
on
the
distribution
of
power
and
responsibilities
between
the
Federal
Government
and
Indian
tribes,
as
specified
by
Executive
Order
13175
(
65
FR
67249,
November
9,
2000).
This
action
also
does
not
have
Federalism
implications
because
it
does
not
have
substantial
direct
effects
on
the
States,
on
the
relationship
between
the
national
government
and
the
States,
or
on
the
distribution
of
power
and
responsibilities
among
the
various
levels
of
government,
as
specified
in
Executive
Order
13132
(
64
FR
43255,
August
10,
1999).
This
action
merely
approves
a
state
rule
implementing
a
Federal
standard,
and
does
not
alter
the
relationship
or
the
distribution
of
power
and
responsibilities
established
in
the
Clean
Air
Act.
This
rule
also
is
not
subject
to
Executive
Order
13045
``
Protection
of
Children
from
Environmental
Health
Risks
and
Safety
Risks''
(
62
FR
19885,
April
23,
1997),
because
it
is
not
economically
significant.
In
reviewing
SIP
submissions,
EPA's
role
is
to
approve
state
choices,
provided
that
they
meet
the
criteria
of
the
Clean
Air
Act.
In
this
context,
in
the
absence
of
a
prior
existing
requirement
for
the
State
to
use
voluntary
consensus
standards
(
VCS),
EPA
has
no
authority
to
disapprove
a
SIP
submission
for
failure
to
use
VCS.
It
would
thus
be
inconsistent
with
applicable
law
for
EPA,
when
it
reviews
a
SIP
submission,
to
use
VCS
in
place
of
a
SIP
submission
that
otherwise
satisfies
the
provisions
of
the
Clean
Air
Act.
Thus,
the
requirements
of
section
12(
d)
of
the
National
Technology
Transfer
and
Advancement
Act
of
1995
(
15
U.
S.
C.
272
note)
do
not
apply.
This
rule
does
not
impose
an
information
collection
burden
under
the
provisions
of
the
Paperwork
Reduction
Act
of
1995
(
44
U.
S.
C.
3501
et
seq.).

B.
Submission
to
Congress
and
the
Comptroller
General
The
Congressional
Review
Act,
5
U.
S.
C.
801
et
seq.,
as
added
by
the
Small
Business
Regulatory
Enforcement
Fairness
Act
of
1996,
generally
provides
that
before
a
rule
may
take
effect,
the
agency
promulgating
the
rule
must
submit
a
rule
report,
which
includes
a
copy
of
the
rule,
to
each
House
of
the
Congress
and
to
the
Comptroller
General
of
the
United
States.
EPA
will
submit
a
report
containing
this
rule
and
other
required
information
to
the
U.
S.
Senate,
the
U.
S.
House
of
Representatives,
and
the
Comptroller
General
of
the
United
States
prior
to
publication
of
the
rule
in
the
Federal
Register.
This
rule
is
not
a
``
major
rule''
as
defined
by
5
U.
S.
C.
804(
2).

C.
Petitions
for
Judicial
Review
Under
section
307(
b)(
1)
of
the
Clean
Air
Act,
petitions
for
judicial
review
of
this
action
must
be
filed
in
the
United
States
Court
of
Appeals
for
the
appropriate
circuit
by
May
27,
2003.
Filing
a
petition
for
reconsideration
by
the
Administrator
of
this
final
rule
does
not
affect
the
finality
of
this
rule
for
the
purposes
of
judicial
review
nor
does
it
extend
the
time
within
which
a
petition
for
judicial
review
may
be
filed,
and
shall
not
postpone
the
effectiveness
of
such
rule
or
action.
This
action
approving
Philadelphia
County's
Air
Management
Regulation
XIII
may
not
be
challenged
later
in
proceedings
to
enforce
its
requirements.
(
See
section
307(
b)(
2).)

List
of
Subjects
in
40
CFR
Part
52
Environmental
protection,
Air
pollution
control,
Carbon
monoxide,
Incorporation
by
reference,
Intergovernmental
relations,
Nitrogen
dioxide,
Ozone,
Particulate
matter,
Reporting
and
recordkeeping
requirements,
Sulfur
oxides,
Volatile
organic
compounds.

Dated:
March
20,
2003.
Donald
S.
Welsh,
Regional
Administrator,
Region
III.


40
CFR
part
52
is
amended
as
follows:

PART
52
 
[
AMENDED]


1.
The
authority
citation
for
part
52
continues
to
read
as
follows:

Authority:
42
U.
S.
C.
7401
et
seq.

Subpart
NN
 
Pennsylvania

2.
Section
52.2020
is
amended
by
adding
paragraph
(
c)(
203)
to
read
as
follows

§
52.2020
Identification
of
plan.

*
*
*
*
*
(
c)
*
*
*
(
203)
Revisions
to
Philadelphia
Air
Management
Regulation
XIII
 
`
`
Pertaining
to
the
Construction,
Modification,
Reactivation,
and
Operation
of
Sources''
submitted
on
May
13,
1999
by
the
Pennsylvania
Department
of
Environmental
Protection
on
behalf
of
Philadelphia
County
Air
Management
Services:
(
i)
Incorporation
by
reference.
(
A)
Letter
of
May
13,
1999
from
the
Pennsylvania
Department
of
Environmental
Protection
on
behalf
of
Philadelphia
County
Air
Management
Services
transmitting
Regulation
XIII
governing
the
construction
of
new
and
modified
sources
and
operation
of
existing
sources
of
air
pollution
in
the
County.
(
B)
Philadelphia
Air
Management
Regulation
XIII
 
`
`
Pertaining
to
the
Construction,
Modification,
Reactivation,
and
Operation
of
Sources'',
except
as
it
pertains
to
the
new
source
review
permit
program
and
the
title
V
operating
permit
program,
effective
October
30,
1995.
(
ii)
Additional
Material.
 
Remainder
of
the
State
submittal
pertaining
to
the
revisions
listed
in
paragraph
(
c)(
203)(
i)
of
this
section.

[
FR
Doc.
03
 
7510
Filed
3
 
27
 
03;
8:
45
am]

BILLING
CODE
6560
 
50
 
P
ENVIRONMENTAL
PROTECTION
AGENCY
40
CFR
Part
721
[
OPPT
 
2002
 
0060;
FRL
 
6758
 
7]

RIN
2070
 
AB27
Significant
New
Uses
of
Certain
Chemical
Substances
AGENCY:
Environmental
Protection
Agency
(
EPA).

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00017
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
OPPT­
2002­
0060­
0001
RECEIVED
OPPT
NCIC
2003
MAR28
7:
16AM
15062
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
ACTION:
Direct
final
rule.

SUMMARY:
EPA
is
promulgating
significant
new
use
rules
(
SNURs)
under
section
5(
a)(
2)
of
the
Toxic
Substances
Control
Act
(
TSCA)
for
62
chemical
substances
which
were
the
subject
of
premanufacture
notices
(
PMNs)
and
subject
to
TSCA
section
5(
e)
consent
orders
issued
by
EPA.
Today's
action
requires
persons
who
intend
to
manufacture,
import,
or
process
these
substances
for
a
significant
new
use
to
notify
EPA
at
least
90
days
before
commencing
the
manufacturing
or
processing
of
the
substance
for
a
use
designated
by
this
rule
as
a
significant
new
use.
The
required
notice
will
provide
EPA
with
the
opportunity
to
evaluate
the
intended
use,
and
if
necessary,
to
prohibit
or
limit
that
activity
before
it
occurs
to
prevent
any
unreasonable
risk
of
injury
to
human
health
or
the
environment.
EPA
is
promulgating
this
SNUR
using
direct
final
procedures.
DATES:
The
effective
date
of
this
rule
is
May
27,
2003
without
further
notice,
unless
EPA
receives
adverse
comment
or
notice
of
intent
to
submit
adverse
comment
before
April
28,
2003.
This
rule
shall
be
promulgated
for
purposes
of
judicial
review
at
1
p.
m.
(
e.
s.
t.)
on
April
11,
2003.
If
EPA
receives
adverse
comment
or
notice
before
April
28,
2003
that
someone
wishes
to
submit
adverse
or
critical
comments
on
EPA's
action
in
establishing
a
SNUR
for
one
or
more
of
the
chemical
substances
subject
to
this
rule,
EPA
will
withdraw
the
SNUR
before
the
effective
date
for
the
substance
for
which
the
comment
or
notice
of
intent
to
comment
is
received
and
will
issue
a
proposed
SNUR
providing
a
30­
day
period
for
public
comment.

ADDRESSES:
Comments
or
notice
of
intent
to
submit
adverse
or
critical
comments
may
be
submitted
electronically,
by
mail,
or
through
hand
delivery/
courier.
Follow
the
detailed
instructions
as
provided
in
Unit
I.
of
the
SUPPLEMENTARY
INFORMATION.
FOR
FURTHER
INFORMATION
CONTACT:
For
general
information
contact:
Barbara
Cunningham,
Acting
Director,
Environmental
Assistance
Division
(
7408M),
Office
of
Pollution
Prevention
and
Toxics,
Environmental
Protection
Agency,
1200
Pennsylvania
Ave.,
NW.,
Washington,
DC
20460
 
0001;
telephone
number:
(
202)
554
 
1404;
e­
mail
address:
TSCA­
Hotline@
epa.
gov.
For
technical
information
contact:
James
Alwood,
Chemical
Control
Division
(
7405M),
Office
of
Pollution
Prevention
and
Toxics,
Environmental
Protection
Agency,
1200
Pennsylvania
Ave.,
NW.,
Washington,
DC
20460
 
0001;
telephone
number:
(
202)
564
 
8974;
e­
mail
address:
alwood.
jim@
epa.
gov.

SUPPLEMENTARY
INFORMATION:

I.
General
Information
A.
Does
this
Action
Apply
to
Me?
You
may
be
potentially
affected
by
this
action
if
you
manufacture,
import,
process,
or
use
the
chemical
substances
contained
in
this
rule.
Potentially
affected
entities
may
include,
but
are
not
limited
to:
 
Chemical
manufacturers
(
NAICS
325),
e.
g.,
Manufacturers,
importers,
processors,
and
users
of
chemicals.
 
Petroleum
and
coal
product
industries
(
NAICS
324),
e.
g.,
Manufacturers,
importers,
processors,
and
users
of
chemicals.
This
listing
is
not
intended
to
be
exhaustive,
but
rather
provides
a
guide
for
readers
regarding
entities
likely
to
be
affected
by
this
action.
Other
types
of
entities
not
listed
in
this
unit
could
also
be
affected.
The
North
American
Industrial
Classification
System
(
NAICS)
codes
have
been
provided
to
assist
you
and
others
in
determining
whether
this
action
might
apply
to
certain
entities.
To
determine
whether
you
or
your
business
may
be
affected
by
this
action,
you
should
carefully
examine
the
applicability
provisions
in
title
40
of
the
Code
of
Federal
Regulations
(
CFR)
at
40
CFR
721.5.
If
you
have
any
questions
regarding
the
applicability
of
this
action
to
a
particular
entity,
consult
the
technical
person
listed
under
FOR
FURTHER
INFORMATION
CONTACT.

B.
How
Can
I
Get
Copies
of
This
Document
and
Other
Related
Information?
1.
Docket.
EPA
has
established
an
official
public
docket
for
this
action
under
docket
identification
(
ID)
number
OPPT
 
2002
 
0060
.
The
official
public
docket
consists
of
the
documents
specifically
referenced
in
this
action,
any
public
comments
received,
and
other
information
related
to
this
action.
Although
a
part
of
the
official
docket,
the
public
docket
does
not
include
Confidential
Business
Information
(
CBI)
or
other
information
whose
disclosure
is
restricted
by
statute.
The
official
public
docket
is
the
collection
of
materials
that
is
available
for
public
viewing
at
the
EPA
Docket
Center,
Rm.
B102­
Reading
Room,
EPA
West,
1301
Constitution
Ave.,
NW.,
Washington,
DC.
The
EPA
Docket
Center
is
open
from
8:
30
a.
m.
to
4:
30
p.
m.,
Monday
through
Friday,
excluding
legal
holidays.
The
EPA
Docket
Center
Reading
Room
telephone
number
is
(
202)
566
 
1744
and
the
telephone
number
for
the
OPPT
Docket,
which
is
located
in
EPA
Docket
Center,
is
(
202)
566
 
0280.
2.
Electronic
access.
You
may
access
this
Federal
Register
document
electronically
through
the
EPA
Internet
under
the
``
Federal
Register''
listings
at
http://
www.
epa.
gov/
fedrgstr/.
The
OPPTS
harmonized
test
guidelines
referenced
in
this
document
are
available
at
http://
www.
epa.
gov/
opptsfrs/
home/
guidelin.
htm.
A
frequently
updated
electronic
version
of
40
CFR
part
721
is
available
at
http://
www.
access.
gpo.
gov/
nara/
cfr/
cfrhtml_
00/
Title_
40/
40cfr
721_
00.
html,
a
beta
site
currently
under
development.
An
electronic
version
of
the
public
docket
is
available
through
EPA's
electronic
public
docket
and
comment
system,
EPA
Dockets.
You
may
use
EPA
Dockets
at
http://
www.
epa.
gov/
edocket/
to
submit
or
view
public
comments,
access
the
index
listing
of
the
contents
of
the
official
public
docket,
and
to
access
those
documents
in
the
public
docket
that
are
available
electronically.
Although
not
all
docket
materials
may
be
available
electronically,
you
may
still
access
any
of
the
publicly
available
docket
materials
through
the
docket
facility
identified
in
Unit
I.
B.
1.
Once
in
the
system,
select
``
search,''
then
key
in
the
appropriate
docket
ID
number.
Certain
types
of
information
will
not
be
placed
in
the
EPA
Dockets.
Information
claimed
as
CBI
and
other
information
whose
disclosure
is
restricted
by
statute,
which
is
not
included
in
the
official
public
docket,
will
not
be
available
for
public
viewing
in
EPA's
electronic
public
docket.
EPA's
policy
is
that
copyrighted
material
will
not
be
placed
in
EPA's
electronic
public
docket
but
will
be
available
only
in
printed,
paper
form
in
the
official
public
docket.
To
the
extent
feasible,
publicly
available
docket
materials
will
be
made
available
in
EPA's
electronic
public
docket.
When
a
document
is
selected
from
the
index
list
in
EPA
Dockets,
the
system
will
identify
whether
the
document
is
available
for
viewing
in
EPA's
electronic
public
docket.
Although
not
all
docket
materials
may
be
available
electronically,
you
may
still
access
any
of
the
publicly
available
docket
materials
through
the
docket
facility
identified
in
Unit
I.
B.
1.
EPA
intends
to
work
towards
providing
electronic
access
to
all
of
the
publicly
available
docket
materials
through
EPA's
electronic
public
docket.
For
public
commenters,
it
is
important
to
note
that
EPA's
policy
is
that
public
comments,
whether
submitted
electronically
or
in
paper,

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00018
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15063
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
will
be
made
available
for
public
viewing
in
EPA's
electronic
public
docket
as
EPA
receives
them
and
without
change,
unless
the
comment
contains
copyrighted
material,
CBI,
or
other
information
whose
disclosure
is
restricted
by
statute.
When
EPA
identifies
a
comment
containing
copyrighted
material,
EPA
will
provide
a
reference
to
that
material
in
the
version
of
the
comment
that
is
placed
in
EPA's
electronic
public
docket.
The
entire
printed
comment,
including
the
copyrighted
material,
will
be
available
in
the
public
docket.
Public
comments
submitted
on
computer
disks
that
are
mailed
or
delivered
to
the
docket
will
be
transferred
to
EPA's
electronic
public
docket.
Public
comments
that
are
mailed
or
delivered
to
the
docket
will
be
scanned
and
placed
in
EPA's
electronic
public
docket.
Where
practical,
physical
objects
will
be
photographed,
and
the
photograph
will
be
placed
in
EPA's
electronic
public
docket
along
with
a
brief
description
written
by
the
docket
staff.

C.
How
and
To
Whom
Do
I
Submit
Comments?
You
may
submit
comments
electronically,
by
mail,
or
through
hand
delivery/
courier.
To
ensure
proper
receipt
by
EPA,
identify
the
appropriate
docket
ID
number
in
the
subject
line
on
the
first
page
of
your
comment.
Please
ensure
that
your
comments
are
submitted
within
the
specified
comment
period.
Comments
received
after
the
close
of
the
comment
period
will
be
marked
``
late.''
EPA
is
not
required
to
consider
these
late
comments.
If
you
wish
to
submit
CBI
or
information
that
is
otherwise
protected
by
statute,
please
follow
the
instructions
in
Unit
I.
D.
Do
not
use
EPA
Dockets
or
e­
mail
to
submit
CBI
or
information
protected
by
statute.
1.
Electronically.
If
you
submit
an
electronic
comment
as
prescribed
in
this
unit,
EPA
recommends
that
you
include
your
name,
mailing
address,
and
an
email
address
or
other
contact
information
in
the
body
of
your
comment.
Also
include
this
contact
information
on
the
outside
of
any
disk
or
CD
ROM
you
submit,
and
in
any
cover
letter
accompanying
the
disk
or
CD
ROM.
This
ensures
that
you
can
be
identified
as
the
submitter
of
the
comment
and
allows
EPA
to
contact
you
in
case
EPA
cannot
read
your
comment
due
to
technical
difficulties
or
needs
further
information
on
the
substance
of
your
comment.
EPA's
policy
is
that
EPA
will
not
edit
your
comment,
and
any
identifying
or
contact
information
provided
in
the
body
of
a
comment
will
be
included
as
part
of
the
comment
that
is
placed
in
the
official
public
docket,
and
made
available
in
EPA's
electronic
public
docket.
If
EPA
cannot
read
your
comment
due
to
technical
difficulties
and
cannot
contact
you
for
clarification,
EPA
may
not
be
able
to
consider
your
comment.
i.
EPA
Dockets.
Your
use
of
EPA's
electronic
public
docket
to
submit
comments
to
EPA
electronically
is
EPA's
preferred
method
for
receiving
comments.
Go
directly
to
EPA
Dockets
at
http://
www.
epa.
gov/
edocket,
and
follow
the
online
instructions
for
submitting
comments.
Once
in
the
system,
select
``
search,''
and
then
key
in
docket
ID
number
OPPT
 
2002
 
0060.
The
system
is
an
``
anonymous
access''
system,
which
means
EPA
will
not
know
your
identity,
e­
mail
address,
or
other
contact
information
unless
you
provide
it
in
the
body
of
your
comment.
ii.
E­
mail.
Comments
may
be
sent
by
e­
mail
to
oppt.
ncic@
epa.
gov,
Attention:
Docket
ID
Number
OPPT
 
2002
 
0060.
In
contrast
to
EPA's
electronic
public
docket,
EPA's
e­
mail
system
is
not
an
``
anonymous
access''
system.
If
you
send
an
e­
mail
comment
directly
to
the
docket
without
going
through
EPA's
electronic
public
docket,
EPA's
e­
mail
system
automatically
captures
your
email
address.
E­
mail
addresses
that
are
automatically
captured
by
EPA's
e­
mail
system
are
included
as
part
of
the
comment
that
is
placed
in
the
official
public
docket,
and
made
available
in
EPA's
electronic
public
docket.
iii.
Disk
or
CD
ROM.
You
may
submit
comments
on
a
disk
or
CD
ROM
that
you
mail
to
the
mailing
address
identified
in
Unit
I.
C.
2.
These
electronic
submissions
will
be
accepted
in
WordPerfect
or
ASCII
file
format.
Avoid
the
use
of
special
characters
and
any
form
of
encryption.
2.
By
mail.
Send
your
comments
to:
Document
Control
Office
(
7407M),
Office
of
Pollution
Prevention
and
Toxics
(
OPPT),
Environmental
Protection
Agency,
1200
Pennsylvania
Ave.,
NW.,
Washington,
DC
20460
 
0001.
3.
By
hand
delivery
or
courier.
Deliver
your
comments
to:
OPPT
Document
Control
Office
(
DCO)
in
EPA
East
Building
Rm.
6428,
1201
Constitution
Ave.,
NW.,
Washington,
DC.
Attention:
Docket
ID
Number
OPPT
 
2002
 
0060.
The
DCO
is
open
from
8
a.
m.
to
4
p.
m.,
Monday
through
Friday,
excluding
legal
holidays.
The
telephone
number
for
the
DCO
is
(
202)
564
 
8930.

D.
How
Should
I
Submit
CBI
To
the
Agency?
Do
not
submit
information
that
you
consider
to
be
CBI
electronically
through
EPA's
electronic
public
docket
or
by
e­
mail.
You
may
claim
information
that
you
submit
to
EPA
as
CBI
by
marking
any
part
or
all
of
that
information
as
CBI
(
if
you
submit
CBI
on
disk
or
CD
ROM,
mark
the
outside
of
the
disk
or
CD
ROM
as
CBI
and
then
identify
electronically
within
the
disk
or
CD
ROM
the
specific
information
that
is
CBI).
Information
so
marked
will
not
be
disclosed
except
in
accordance
with
procedures
set
forth
in
40
CFR
part
2.
In
addition
to
one
complete
version
of
the
comment
that
includes
any
information
claimed
as
CBI,
a
copy
of
the
comment
that
does
not
contain
the
information
claimed
as
CBI
must
be
submitted
for
inclusion
in
the
public
docket
and
EPA's
electronic
public
docket.
If
you
submit
the
copy
that
does
not
contain
CBI
on
disk
or
CD
ROM,
mark
the
outside
of
the
disk
or
CD
ROM
clearly
that
it
does
not
contain
CBI.
Information
not
marked
as
CBI
will
be
included
in
the
public
docket
and
EPA's
electronic
public
docket
without
prior
notice.
If
you
have
any
questions
about
CBI
or
the
procedures
for
claiming
CBI,
please
consult
the
technical
person
listed
under
FOR
FURTHER
INFORMATION
CONTACT.

E.
What
Should
I
Consider
as
I
Prepare
My
Comments
for
EPA?

We
invite
you
to
provide
your
views
on
the
various
options
we
propose,
new
approaches
we
haven't
considered,
the
potential
impacts
of
the
various
options
(
including
possible
unintended
consequences),
and
any
data
or
information
that
you
would
like
the
Agency
to
consider
during
the
development
of
the
final
action.
You
may
find
the
following
suggestions
helpful
for
preparing
your
comments:
1.
Explain
your
views
as
clearly
as
possible.
2.
Describe
any
assumptions
that
you
used.
3.
Provide
copies
of
any
technical
information
and/
or
data
you
used
that
support
your
views.
4.
If
you
estimate
potential
burden
or
costs,
explain
how
you
arrived
at
the
estimate
that
you
provide.
5.
Provide
specific
examples
to
illustrate
your
concerns.
6.
Offer
alternative
ways
to
improve
the
rule.
7.
Make
sure
to
submit
your
comments
by
the
deadline
in
this
document.
8.
To
ensure
proper
receipt
by
EPA,
be
sure
to
identify
the
docket
ID
number
assigned
to
this
action
in
the
subject
line
on
the
first
page
of
your
response.
You
may
also
provide
the
name,
date,
and
Federal
Register
citation.

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00019
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15064
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
II.
Background
A.
What
Action
is
the
Agency
Taking?
This
SNUR
will
require
persons
to
notify
EPA
at
least
90
days
before
commencing
manufacturing,
importing,
or
processing
a
substance
for
any
activity
designated
by
this
SNUR
as
a
significant
new
use.
The
supporting
rationale
and
background
to
this
rule
are
more
fully
set
out
in
the
preamble
to
EPA's
first
direct
final
SNUR
published
in
the
Federal
Register
of
April
24,
1990
(
55
FR
17376).
Consult
that
preamble
for
further
information
on
the
objectives,
rationale,
and
procedures
for
the
rules
and
on
the
basis
for
significant
new
use
designations
including
provisions
for
developing
test
data.

B.
What
is
the
Agency's
Authority
for
Taking
this
Action?
Section
5(
a)(
2)
of
TSCA
(
15
U.
S.
C.
2604(
a)(
2))
authorizes
EPA
to
determine
that
a
use
of
a
chemical
substance
is
a
``
significant
new
use.''
EPA
must
make
this
determination
by
rule
after
considering
all
relevant
factors,
including
those
listed
in
section
5(
a)(
2)
of
TSCA.
Once
EPA
determines
that
a
use
of
a
chemical
substance
is
a
significant
new
use,
section
5(
a)(
1)(
B)
of
TSCA
requires
persons
to
submit
a
notice
to
EPA
at
least
90
days
before
they
manufacture,
import,
or
process
the
substance
for
that
use.
The
mechanism
for
reporting
under
this
requirement
is
established
under
40
CFR
721.5.

C.
Applicability
of
General
Provisions
General
provisions
for
SNURs
appear
under
subpart
A
of
40
CFR
part
721.
These
provisions
describe
persons
subject
to
the
rule,
recordkeeping
requirements,
exemptions
to
reporting
requirements,
and
applicability
of
the
rule
to
uses
occurring
before
the
effective
date
of
the
final
rule.
Provisions
relating
to
user
fees
appear
at
40
CFR
part
700.
Persons
subject
to
this
SNUR
must
comply
with
the
same
notice
requirements
and
EPA
regulatory
procedures
as
submitters
of
PMNs
under
section
5(
a)(
1)(
A)
of
TSCA.
In
particular,
these
requirements
include
the
information
submission
requirements
of
TSCA
section
5(
b)
and
5(
d)(
1),
the
exemptions
authorized
by
TSCA
section
5
(
h)(
1),
(
h)(
2),
(
h)(
3),
and
(
h)(
5),
and
the
regulations
at
40
CFR
part
720.
Once
EPA
receives
a
SNUR
notice,
EPA
may
take
regulatory
action
under
TSCA
section
5(
e),
5(
f),
6,
or
7
to
control
the
activities
on
which
it
has
received
the
SNUR
notice.
If
EPA
does
not
take
action,
EPA
is
required
under
TSCA
section
5(
g)
to
explain
in
the
Federal
Register
its
reasons
for
not
taking
action.
Persons
who
intend
to
export
a
substance
identified
in
a
proposed
or
final
SNUR
are
subject
to
the
export
notification
provisions
of
TSCA
section
12(
b).
The
regulations
that
interpret
TSCA
section
12(
b)
appear
at
40
CFR
part
707.
Persons
who
intend
to
import
a
chemical
substance
identified
in
a
final
SNUR
are
subject
to
the
TSCA
section
13
import
certification
requirements,
which
are
codified
at
19
CFR
12.118
through
12.127
and
127.28.
Such
persons
must
certify
that
they
are
in
compliance
with
SNUR
requirements.
The
EPA
policy
in
support
of
the
import
certification
appears
at
40
CFR
part
707.

III.
Substances
Subject
to
this
Rule
EPA
is
establishing
significant
new
use
and
recordkeeping
requirements
for
the
following
chemical
substances
under
40
CFR
part
721,
subpart
E.
In
this
unit,
EPA
provides
a
brief
description
for
each
substance,
including
its
PMN
number,
chemical
name
(
generic
name
if
the
specific
name
is
claimed
as
CBI),
CAS
number
(
if
assigned
for
non­
confidential
chemical
identities),
basis
for
the
action
taken
by
EPA
in
the
TSCA
section
5(
e)
consent
order
or
as
a
non­
section
5(
e)
SNUR
for
the
substance
(
including
the
statutory
citation
and
specific
finding),
toxicity
concern,
and
the
CFR
citation
assigned
in
the
regulatory
text
section
of
this
rule.
The
specific
uses
which
are
designated
as
significant
new
uses
are
cited
in
the
regulatory
text
section
of
this
document
by
reference
to
40
CFR
part
721,
subpart
E
where
the
significant
new
uses
are
described
in
detail.
Certain
new
uses,
including
production
limits
and
other
uses
designated
in
the
rule
are
claimed
as
CBI.
The
procedure
for
obtaining
confidential
information
is
set
out
in
Unit
VII.
Where
the
underlying
TSCA
section
5(
e)
consent
order
prohibits
the
PMN
submitter
from
exceeding
a
specified
production
limit
without
performing
specific
tests
to
determine
the
health
or
environmental
effects
of
a
substance,
the
tests
are
described
in
this
unit.
As
explained
further
in
Unit
VI.,
the
SNUR
for
such
substances
contains
the
same
production
limit,
and
exceeding
the
production
limit
is
defined
as
a
significant
new
use.
Persons
who
intend
to
exceed
the
production
limit
must
notify
the
Agency
by
submitting
a
significant
new
use
notice
(
SNUN)
at
least
90
days
in
advance.
In
addition,
this
unit
describes
tests
that
are
recommended
by
EPA
to
provide
sufficient
information
to
evaluate
the
substance,
but
for
which
no
production
limit
has
been
established
in
the
TSCA
section
5(
e)
consent
order.
Descriptions
of
recommended
tests
are
provided
for
informational
purposes.
Data
on
potential
exposures
or
releases
of
the
substances,
testing
other
than
that
specified
in
the
TSCA
section
5(
e)
consent
order
for
the
substances,
or
studies
on
analogous
substances,
which
may
demonstrate
that
the
significant
new
uses
being
reported
do
not
present
an
unreasonable
risk,
may
be
included
with
significant
new
use
notification.
Persons
submitting
a
SNUN
must
comply
with
the
same
notice
requirements
and
EPA
regulatory
procedures
as
submitters
of
PMNs,
as
stated
in
40
CFR
721.1(
c),
including
submission
of
test
data
on
health
and
environmental
effects
as
described
in
40
CFR
720.50.
EPA
is
not
publishing
SNURs
for
PMNs
for
P
 
99
 
309,
P
 
99
 
492/
493/
494/
495/
496/
497,
P
 
99
 
847,
P
 
99
 
1106,
P
 
99
 
1166,
and
P
 
99
 
1389,
which
are
subject
to
a
final
TSCA
section
5(
e)
consent
order.
The
TSCA
section
5(
e)
consent
orders
for
these
substances
are
derived
from
an
exposure
finding
based
solely
on
substantial
production
volume
and
significant
or
substantial
human
exposure
and/
or
release
to
the
environment
of
substantial
quantities.
For
these
cases
there
were
limited
or
no
toxicity
data
available
for
the
PMN
substances.
In
such
cases,
EPA
regulates
the
new
chemical
substances
under
TSCA
section
5(
e)
by
requiring
certain
toxicity
tests.
For
instance,
chemical
substances
with
potentially
substantial
releases
to
surface
waters
would
be
subject
to
toxicity
testing
of
aquatic
organisms
and
chemicals
with
potentially
substantial
human
exposures
would
be
subject
to
health
effects
testing
for
mutagenicity,
acute
effects,
and
subchronic
effects.
However,
for
these
substances,
the
short­
term
toxicity
testing
required
by
the
TSCA
section
5(
e)
consent
order
is
usually
completed
within
1
to
2
years
of
notice
of
commencement
(
NOC).
EPA's
experience
with
exposure­
based
SNURs
requiring
short­
term
testing
is
that
the
SNUR
is
often
revoked
within
1
to
2
years
when
the
test
results
are
received.
Rather
than
issue
and
revoke
SNURs
in
such
a
short
span
of
time,
EPA
will
defer
publication
of
exposure­
based
SNURs
until
either
a
NOC
or
data
demonstrating
risk
are
received
unless
the
toxicity
testing
required
is
longterm
EPA
is
issuing
this
explanation
and
notification
as
required
in
40
CFR
721.160(
a)(
2)
as
it
has
determined
that
SNURs
are
not
needed
at
this
time
for
these
substances
which
are
subject
to
a
final
section
5(
e)
consent
order
under
TSCA.
PMN
Numbers
P
 
98
 
0082/
0083/
0084
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00020
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15065
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
Chemical
names:
(
generic)
(
P
 
98
 
0082
and
P
 
98
 
0083)
Alkoxylated
alkylpolyol
acrylates,
adduct
with
alkylamine
and
(
generic)
(
P
 
98
 
0084)
Alkoxylated
alkylpolyol
acrylates.
CAS
numbers:
Not
available.
Basis
for
action:
The
PMN
substances
will
be
used
as
binders
for
UV
or
electron
beam
curable
coatings
for
wood,
paper,
and
plastics.
Based
on
structural
analogy
to
aliphatic
amines,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
1
part
per
billion
(
ppb)
of
the
PMN
substances
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substances
are
not
released
to
surface
waters,
as
described
in
the
PMNs,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substances
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substances
resulting
in
release
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substances
meet
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substances.
All
tests
should
be
conducted
with
the
static
methods
and
nominal
concentrations.
CFR
citation:
40
CFR
721.465.
PMN
Numbers
P
 
98
 
0497
and
P
 
98
 
0509
Chemical
name:
Propanoic
acid,
2­
methyl­,
(
1R,
2R,
4R)­
1,7,7­
trimethylbicyclo[
2.2.1]
hept­
2­
yl
ester,
rel­.
CAS
number:
85586
 
67
 
0.
Basis
for
action:
The
PMN
substances
will
be
used
as
a
fragrance
compound
for
air
fresheners,
soaps,
shampoo,
household
detergents,
and
bleach.
Toxicity
data
on
structurally
similar
esters
indicate
that
the
PMN
substances
may
cause
toxicity
to
aquatic
organisms.
Based
on
these
data,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
of
10
ppb
of
the
PMN
substances
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substances
are
not
released
to
surface
waters
in
significant
quantities,
EPA
has
not
determined
that
the
proposed
processing
and
use
of
the
substances
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
an
increase
in
production
volume
may
result
in
releases
of
the
PMN
substances
to
surface
waters
which
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substances
meet
the
concern
criteria
at
§
721.170
(
b)(
4)(
ii).
Recommended
testing:
The
Agency
has
determined
that
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft))
would
help
to
characterize
possible
environmental
effects
of
the
substances.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
CFR
citation:
40
CFR
721.4486.
PMN
Number
P
 
98
 
0823
Chemical
name:
Dodecanoic
acid,
12­
amino­.
CAS
number:
693
 
57
 
2.
Effective
date
of
section
5(
e)
consent
order:
August
18,
2000.
Basis
for
section
5(
e)
consent
order:
The
order
was
issued
under
section
5(
e)(
1)(
A)(
i)
and
section
5(
e)(
1)(
A)(
ii)
of
TSCA
based
on
a
finding
that
this
substance
may
present
an
unreasonable
risk
of
injury
to
human
health
and
the
environment.
Toxicity
concern:
This
PMN
substance
will
be
used
as
a
raw
material
for
Nylon­
12.
EPA
has
identified
a
health
concern
for
carcinogenicity
via
inhalation
exposure
based
on
analogy
to
11­
aminoundodecanoic
acid
which
caused
neoplastic
nodules
in
the
liver
and
transitional
cell
carcinomas
in
the
urinary
bladder
of
male
rats.
Recommended
testing:
EPA
has
determined
that
a
carcinogenicity
study
(
OPPTS
870.4200
test
guideline)
would
help
to
characterize
the
human
health
effects.
CFR
citation:
40
CFR
721.2584.
PMN
Number
P
 
98
 
1125
Chemical
name:
(
generic)
Fatty
acid,
reaction
product
with
substituted
oxirane,
formaldehyde­
phenol
polymer
glycidyl
ether,
substituted
propylamine
and
polythylenepolyamines.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
curing
agent
for
epoxy
coating
systems.
Based
on
structural
analogy
to
aliphatic
amines,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
10
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substance
is
not
released
to
surface
water
above
10
ppb,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
above
10
ppb
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft));
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)),
and
a
fish
acute
toxicity
mitigated
by
humic
acid
(`
HA')
of
10
and
20
mg
HA
per
liter
diluent
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
All
studies
should
use
the
static
methods
and
nominal
concentrations.
CFR
citation:
40
CFR
721.6181.
PMN
Number
P
 
98
 
1262
Chemical
name:
(
generic)
Reaction
product
of
alkylene
diamine,
MD1,
substituted
carbomonocyclic
amine
and
alkylamine.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
test
data
on
structurally
similar
neutral
organic
chemicals,
the
PMN
substance
may
cause
toxicity
to
aquatic
organisms.
Based
on
the
data,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
1
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
the
results
of
the
following
testing
would
help
characterize
the
environmental
effects
of
the
PMN
substance:
a
Melting
point
(
OPPTS
830.7200
test
guideline),
a
fish
early­
life
stage
toxicity
test
(
OPPTS
850.1400
test
guideline
(
public
draft)),
and
a
daphnid
chronic
toxicity
test
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00021
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15066
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
(
OPPTS
850.1300
test
guideline
(
public
draft)).
The
fish
and
daphnid
tests
should
be
conducted
with
the
flowthrough
methods
and
measured
concentrations,
and
hardness
of
dilution
water
less
than
180
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.2582.
PMN
Number
P
 
99
 
0044
Chemical
name:
Formaldehyde,
polymer
with
phenol
and
1,2,3­
propanetriol,
methylated.
CAS
number:
209810
 
57
 
1.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
bonding
agent
for
mineral
aggregates.
Based
on
structural
analogy
to
phenols,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
2
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substance
is
not
released
to
surface
water
above
3
ppb,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
releases
to
surface
water
above
3
ppb
may
cause
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
an
activated
sludge
sorption
isotherm
test
(
OPPTS
835.1110
test
guideline),
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphid
tests
should
be
performed
under
flow
through
methods
and
measured
concentrations.
The
algal
test
should
be
performed
under
static
methods
and
measured
concentrations.
CFR
citation:
40
CFR
721.3807.
PMN
Number
P
 
99
 
0510
Chemical
name:
(
generic)
Hexamethylenediamine
adduct
of
substituted
piperidinyloxy.
CAS
number:
Not
available.
Effective
date
of
section
5(
e)
consent
order:
December
24,
1999.
Basis
for
section
5(
e)
consent
order:
The
order
was
issued
under
section
5(
e)(
1)(
A)(
i)
and
section
5(
e)(
1)(
A)(
ii)(
i)
of
TSCA
based
on
a
finding
that
this
substance
may
present
an
unreasonable
risk
of
injury
to
human
health.
Toxicity
concern:
Based
on
submitted
data
on
a
28­
day
subchronic
study
in
rats,
the
PMN
substance
has
been
shown
to
cause
potential
liver
toxicity,
hemolytic
effects,
and
immunotoxicity
from
inhalation
exposure
to
the
PMN
substance.
Recommended
testing:
A
90­
day
subchronic
oral
study
in
rats
with
emphasis
on
hematology,
the
immune
system,
and
male
reproductive
system
(
OPPTS
870.3100
test
guideline)
would
help
to
characterize
possible
effects
of
the
substance.
The
PMN
submitter
has
agreed
not
to
exceed
the
production
volume
limit
without
performing
the
90­
day
subchronic
oral
study.
CFR
citation:
40
CFR
721.6205.
PMN
Number
P
 
99
 
0669
Chemical
name:
Oxirane,
methyl­,
polymer
with
oxirane,
mono(
3,5,5,­
trimethylhexyl)
ether.
CAS
number:
204336
 
40
 
3.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
structural
analogy
to
nonionic
surfactants,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
of
600
ppb
in
surface
waters.
Since
significant
environmental
exposure
is
unlikely,
as
the
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
releases
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substances.
The
fish
and
daphnid
tests
should
be
conducted
with
the
flow­
through
methods
and
measured
concentrations,
and
the
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
CFR
citation:
40
CFR
721.522.
PMN
Number
P
 
99
 
0848
Chemical
name:
(
generic)
Alkenyl
carboxylate,
metal
salt.
CAS
number:
Not
available.
Effective
date
of
section
5(
e)
consent
order:
August
2,
2000.
Basis
for
section
5(
e)
consent
order:
The
order
was
issued
under
section
5(
e)(
1)(
A)(
i)
and
section
5(
e)(
1)(
A)(
ii)(
I)
of
TSCA
based
on
a
finding
that
this
substance
is
expected
to
enter
the
environment
in
substantial
quantities
and
may
present
an
unreasonable
risk
of
injury
to
the
environment.
Toxicity
concern:
Based
on
analogy
to
anionic
surfactants
the
PMN
substance
may
be
toxic
to
aquatic
organisms
at
concentrations
as
low
as
1
ppb.
Recommended
testing:
EPA
has
determined
that
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)),
an
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations
and
hardness
of
dilution
water
with
less
than
180
mg/
L
as
CaC03.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
The
PMN
submitter
has
agreed
not
to
exceed
the
production
volume
limit
without
performing
these
tests.
CFR
citation:
40
CFR
721.2093.
PMN
Number
P
 
99
 
0873
Chemical
name:
(
generic)
Propanetriol
polyalkylenepolyolamine
aryl
aldimine.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
binder
for
industrial
coating.
Based
on
additional
information
and
structural
analogy
to
schiff
bases
and
aliphatic
amines,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
2
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substance
is
not
released
to
surface
waters,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)),
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
chronic
toxicity
study
(
OPPTS
850.1300
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
the
flowthrough
methods
and
measured
concentrations
and
the
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00022
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15067
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
CFR
citation:
40
CFR
721.910.
PMN
Number
P
 
99
 
0874
Chemical
name:
(
generic)
Modified
polymer
of
vinyl
acetate
and
quaternary
ammonium
compound.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
modified
polyvinyl
alcohol.
Based
on
submitted
toxicity
data
for
other
high
molecular
weight,
water
swellable
polymers,
EPA
has
identified
health
concerns
for
inhalation
exposure.
Since
significant
inhalation
exposure
is
unlikely
when
the
substance
is
used
as
identified
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
domestic
manufacture
of
the
PMN
may
lead
to
inhalation
exposure
which
could
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii).
Recommended
testing:
EPA
has
determined
that
a
90­
day
inhalation
toxicity
study
with
a
60­
day
holding
period
(
OPPTS
870.3465
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
Attention
should
be
given
to
the
lungs,
including
histopathology
of
the
lungs
(
inflamation,
epithelial
hyperplasia,
and
fibrosis),
bronchoalvelar
lavage
(
BAL)
analysis
for
markers
of
lung
injury,
and
lung
burden
analysis
for
clearance
of
the
test
material
(
EPA
 
748
 
R
 
96
 
001).
The
neurotoxicity
components
and
examination
of
organs
other
than
the
lungs
are
not
required.
CFR
citation:
40
CFR
721.8658.
PMN
Number
P
 
99
 
0965
Chemical
name:
Furan,
octafluorotetrahydro­.
CAS
number:
773
 
14
 
8.
Basis
for
action:
The
PMN
substance
will
be
used
as
heat
transfer
agent.
EPA
believes
that
other
uses
of
the
PMN
substance
are
likely
and
they
have
the
potential
for
more
widespread
environmental
exposure
causing
potential
atmospheric
changes.
EPA
is
concerned
that
such
atmospheric
changes
may
contribute
to
global
warming.
Since
significant
environmental
exposure
is
unlikely,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
may
result
in
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
infrared
absorption,
destruction
of
OH
by
radical
and
rate
of
production
of
HF
for
global
warming
would
help
to
characterize
the
atmospheric
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.3818.
PMN
Number
P
 
99
 
0990
Chemical
name:
Cobaltate
(
5­),
bis[
4­[[
6­
[(
4­
amino­
6­
chloro­
1,3,5­
triazin­
2­
yl)
amio]­
1­
hydroxy­
3­
sulfo­
2­
naphthalenyl]
azo]­
3­
hydroxy­
7­
nitro­
1­
naphthalenesulfonato(
4­)]­,
pentasodium.
CAS
number:
91144
 
26
 
2.
Basis
for
action:
Based
on
structural
analogues
and
submitted
test
data,
EPA
has
identified
health
concerns
for
carcinogenicity
and
mutagenicity
from
inhalation
exposure
to
the
PMN
substance.
Since
significant
worker
exposure
is
unlikely
because
inhalation
exposure
is
not
expected
when
the
substance
is
used
with
protective
equipment
as
identified
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
uses
of
the
substance
other
than
as
described
in
the
PMN
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
1)(
i)(
B)
and
(
b)(
1)(
i)(
C).
Recommended
testing:
EPA
has
determined
that
a
combined
chronic
toxicity/
carcinogenicity
study
(
OPPTS
870.4300
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.5283.
PMN
Number
P
 
99
 
1167
Chemical
name:
L­
aspartic
acid,
N,
N'­
[(
1E)
­
1,2
­
ethenediylbis[(
3­
sulfo­
4,
1­
phenylene)
imino[
6­(
phenylamino)­
1,3,5­
triazine­
4,2
­
diyl]]]
bis­,
hexasodium
salt.
CAS
number:
205764
 
98
 
3.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
fluorescent
whitener
for
coated
paper.
Based
on
submitted
test
data,
EPA
has
identified
concerns
for
liver
effects.
Since
significant
worker
exposure
is
unlikely
because
there
would
not
be
significant
inhalation
exposure
for
the
use
identified
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
as
described
in
the
PMN
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
uses
of
the
substance
in
a
powder
form
or
domestic
manufacture
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
i).
Recommended
testing:
EPA
has
determined
that
a
90­
day
subchronic
oral
toxicity
study
in
rodents
(
OPPTS
870.3100
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.4575.
PMN
Number
P
 
99
 
1189
Chemical
name:
2­
propenoic
acid,
2­
methyl­,
C11­
14­
isoalkyl
esters,
C13­
rich.
CAS
number:
85736
 
97
 
6.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
monomer
for
casting
automotive
parts
adhesives
or
as
an
impregnation
fluid.
Based
on
analogy
to
structurally
similar
methacrylates
and
esters,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
1
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substance
is
not
released
to
surface
waters
above
1
ppb,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
above
1
ppb
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
The
Agency
has
determined
that
the
results
of
the
following
testing
would
help
to
characterize
possible
environmental
effects
of
the
substance:
A
ready
biodegradability
test
(
OPPTS
835.3110
test
guideline);
a
fish
early­
life
stage
toxicity
study
(
OPPTS
850.1400
test
guideline
(
public
draft));
a
mysid
chronic
toxicity
study
(
OPPTS
850.1350
test
guideline
(
public
draft))
for
21
days,
flow­
through
methods
and
measured
concentrations;
and
a
saltwater
algal
toxicity
study,
tiers
I
and
II
(
OPPTS
850.5400
test
guideline
(
public
draft))
with
the
static
methods
and
measured
concentrations.
CFR
citation:
40
CFR
721.4792.
PMN
Numbers
P
 
99
 
1191
and
P
 
99
 
1192
Chemical
name:
(
generic)
Rare
earth
phosphate.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substances
will
be
used
as
phosphors.
Based
on
structural
analogy
to
soluble
salts
and
test
data
for
inorganic
phosphates,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
2
ppb
of
the
PMN
substances
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substances
are
not
released
to
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00023
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15068
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
surface
waters
above
10
ppb,
as
described
in
the
PMNs,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substances
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substances
resulting
in
release
to
surface
waters
above
10
ppb
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substances
meet
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substances.
A
flow­
through
method
with
measured
concentrations
of
the
rare
earth
metal
is
recommended
for
the
fish
and
daphnid
study
and
the
static
method
with
measured
concentrations
for
green
algae.
In
addition,
the
test
dilution
water
and/
or
test
medium
should
have
a
measured
hardness
of
less
than
180.0
mg/
L
as
CaC03
and
a
total
organic
carbon
(
TOC)
concentration
of
less
than
2.0
mg
TOC/
L.
CFR
citation:
40
CFR
721.6005.
PMN
Number
P
 
99
 
1287
Chemical
name:
(
generic)
Alkylaminated
polyolefin.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
gasoline
fuel
additive.
Based
on
structural
analogy
to
aliphatic
amines,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
40
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
These
tests
should
be
conducted
with
static
methods
and
nominal
concentrations,
total
organic
carbon
TOC
of
dilution
water
<
2.0
mg
TOC/
L,
hardness
of
dilution
water
<
180.0
mg/
L
as
CaC03,
and
stock
solution
adjusted
to
pH
7.0
with
HCl.
CFR
citation:
40
CFR
721.6178.
PMN
Number
P
 
99
 
1327
Chemical
name:
Propane,
1,1,1,3,3­
pentachloro­.
CAS
number:
23153
 
23
 
3.
Basis
for
action:
The
PMN
substance
will
be
used
as
an
intermediate
for
hydrofluorocarbon
production.
Based
on
submitted
test
data,
EPA
has
identified
health
concerns
for
carcinogenicity,
liver
and
kidney
toxicity.
Based
on
submitted
data
on
hexachloropropane,
concern
for
immunotoxicity
was
identified.
Also,
the
Agency
identified
concern
for
neurotoxicity,
reproductive
toxicity
in
males
and
females,
and
concern
for
irritation
and
lesions
in
nasal
passages
and
respiratory
passages
based
on
test
data
on
other
structural
analogues.
Since
significant
worker
exposure
is
unlikely
when
the
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
use
of
the
substance
other
than
as
described
in
the
PMN
could
result
in
exposures
which
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
1)(
i)(
A),
(
b)(
3)(
i),
and
(
b)(
3)(
ii).
Recommended
testing:
EPA
has
determined
that
a
prenatal
developmental
toxicity
study
(
OPPTS
870.3700
test
guideline),
carcinogenicity
study
(
OPPTS
870.4200
test
guideline),
and
a
reproduction
fertility
effects
study
(
OPPTS
870.3800
test
guideline)
by
the
inhalation
route
will
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.533.
PMN
Number
P
 
99
 
1346
Chemical
name:
Silane,
triethoxy
(
3,3,4,4,5,5,6,6,7,7,8,8,8­
tridecafluorooctyl)­.
CAS
number:
51851
 
37
 
7.
Basis
for
action:
The
PMN
substance
will
be
used
as
in
anti­
graffiti
coatings
as
described
in
the
PMN.
Based
on
structural
analogy
to
alkoxysilanes,
EPA
has
identified
health
concerns
for
lung
toxicity.
Since
significant
worker
exposure
is
unlikely,
when
the
substance
is
used
with
protective
equipment
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
use
of
the
PMN
substance
other
than
as
described
in
the
PMN
could
result
in
exposures
which
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii).
Recommended
testing:
EPA
has
determined
that
a
90­
day
subchronic
inhalation
toxicity
study
in
rats
(
OPPTS
870.3465
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.9504.
PMN
Number
P
 
99
 
1366
Chemical
name:
(
generic)
4,6­
Disubstituted
pyrimidine.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
starting
material
for
synthesis
of
a
chemical
intermediate.
EPA
has
identified
health
concerns
for
neurotoxicity
and
immunotoxicity
(
effects
to
the
spleen)
based
on
test
data
on
an
analogous
substance,
concerns
for
carcinogenicity
and
developmental
toxicity
based
on
the
potential
for
the
PMN
substance
to
act
as
an
arylating
agent
or
as
an
antimetabolite.
Since
significant
worker
exposure
is
unlikely,
when
the
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
domestic
manufacture
could
result
in
exposures
which
may
cause
serious
chronic
and
developmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii)
and
(
b)(
1)(
i)(
C).
Recommended
testing:
EPA
has
determined
that
a
90­
day
subchronic
oral
toxicity
study
in
rodents
(
OPPTS
870.3100
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.8920.
PMN
Number
P
 
99
 
1399
Chemical
name:
(
generic)
Aromatic
epoxide
resin.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
thermoset
resin.
EPA
has
identified
health
concerns
for
mutagenicity,
carcinogenicity,
developmental
toxicity,
male
reproductive
effects,
liver
and
kidney
toxicity
based
on
the
epoxide
groups.
Since
significant
worker
exposure
is
unlikely,
when
the
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00024
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15069
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
use
of
the
PMN
substance
other
than
as
described
in
the
PMN
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii).
Recommended
testing:
EPA
has
determined
that
a
90­
day
subchronic
oral
toxicity
study
in
rodents
with
attention
to
pathology
of
the
reproductive
organs
(
OPPTS
870.3100
test
guideline),
a
reproduction
fertility
effects
study
(
OPPTS
870.3800
test
guideline),
and
a
combined
chronic
toxicity/
carcinogenicity
study
(
OPPTS
870.4300
test
guideline)
would
help
to
characterize
the
health
effects
of
the
substance.
CFR
citation:
40
CFR
721.2673.
PMN
Number
P
 
00
 
0045
Chemical
name:
(
generic)
Benzenediazonium,
[[[[(
substituted)
azo]
phenyl]
sulfonyl]
amino]­,
coupled
with
aminophenol,
diazotized
aminobenzoic
acid,
diazotized
(
substituted)
benzenesulfonic
acid
and
naphthalenol.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
submitted
test
data,
EPA
has
identified
health
concerns
for
methemoglobinemia.
Since
significant
worker
exposure
is
unlikely
when
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
cause
significant
adverse
effects.
EPA
has
determined,
however,
that
domestic
manufacture
may
result
in
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii).
Recommended
testing:
EPA
has
determined
that
a
90­
day
subchronic
oral
toxicity
study
in
rodents
(
OPPTS
870.3100
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.5286.
PMN
Number
P
 
00
 
0067
Chemical
name:
(
generic)
Alkyl
heteropolycyclic­
aniline.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
an
industrial
intermediate.
Based
on
test
data
and
on
structural
analogy
to
anilines,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
1
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
substance
is
not
released
to
surface
water
above
1
ppb
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
above
1
ppb
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
i)
and
(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
daphnid
chronic
toxicity
test
(
OPPTS
850.1300
test
guideline
(
public
draft)),
a
fish
early­
life
stage
toxicity
test
(
OPPTS
850.1400
test
guideline
(
public
draft))
conducted
with
flow­
through
methods
and
measured
concentrations,
dilution
water
hardness
<
180.0
mg/
L
as
CaC03,
and
a
Porous
Pot
(
OPPTS
835.3220
test
guideline)
would
help
to
characterize
the
environmental
effects.
CFR
citation:
40
CFR
721.4136.
PMN
Number
P
 
00
 
0094
Chemical
name:
(
generic)
Salt
of
a
substituted
sulfonated
aryl
azo
compound.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
colorant
for
coating
compositions.
EPA
has
identified
health
concerns
for
testicular
effects,
blood
effects,
and
liver
toxicity
based
on
submitted
test
data.
Since
significant
worker
exposure
is
unlikely,
when
the
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined
however,
that
domestic
manufacture
could
result
in
exposures
which
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
i).
Recommended
testing:
EPA
has
determined
that
a
90­
day
subchronic
oral
toxicity
study
in
rodents
(
OPPTS
870.3100
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.9597.
PMN
Number
P
 
00
 
0108
Chemical
name:
(
generic)
Alkoxyaminoalkyl
coumarin.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
chemical
tracer.
Based
on
structural
analogy
to
coumarins,
EPA
has
identified
health
concerns
for
developmental
toxicity
and
carcinogenicity.
Since
significant
worker
exposure
is
unlikely
when
the
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
domestic
manufacture
could
result
in
exposures
which
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii)
and
(
b)(
1)(
i)(
C).
Recommended
testing:
EPA
has
determined
that
a
90­
day
subchronic
oral
study
in
rodents
(
OPPTS
870.3100
test
guideline)
and
a
prenatal
developmental
toxicity
study
(
OPPTS
870.3700
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.2155.
PMN
Number
P
 
00
 
0202
Chemical
name:
(
generic)
Reaction
product
of
substituted
aromatic
diol,
formaldehyde
and
alkanolamine,
propoxylated.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
foam
insulation.
Based
on
structural
analogy
to
aliphatic
amines,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
10
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
water
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
All
tests
should
be
conducted
with
static
methods
and
nominal
concentrations,
dilution
water
total
organic
carbon
TOC
<
2.0
mg
TOC/
L
dilution
water
hardness
<
180.0
mg/
L
as
CaC03,
and
stock
solution
adjusted
to
pH
7.0.
CFR
citation:
40
CFR
721.8085.
PMN
Number
P
 
00
 
0330
Chemical
name:
Oxirane,
[[[(
1R,
2S,
5R)­
5­
methyl­
2­(
1­
methylethyl)
cyclohexyl]
oxy]
methyl]­.
CAS
number:
249297
 
16
 
3.

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00025
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15070
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
Basis
for
action:
The
PMN
substance
will
be
used
as
a
chemical
intermediate.
Based
on
data
for
monoepoxides,
EPA
has
identified
health
concerns
for
mutagenicity,
carcinogenicity,
male
reproductive
toxicity,
developmental
toxicity,
and
liver
and
kidney
toxicity
for
the
epoxide.
Also,
based
on
analogy
to
epoxides,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
30
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
worker
and
environmental
exposure
is
unlikely
when
the
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
manufacturing,
processing,
and
use
of
the
PMN
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
use
of
the
substance
other
than
as
an
intermediate
could
result
in
exposures
which
may
cause
serious
health
effects
and
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii),
(
b)(
1)(
i)
(
C),
and
(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
90­
day
subchronic
oral
toxicity
study
in
rodents
(
OPPTS
870.3100
test
guideline),
with
attention
to
pathology
of
the
reproductive
organs,
and
a
carcinogenicity
study
(
OPPTS
870.4200
test
guideline)
would
help
to
characterize
the
health
effects
of
the
substance.
In
addition,
the
following
acute
aquatic
toxicity
tests
would
help
to
characterize
the
environmental
effects.
A
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)).
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
CFR
citation:
40
CFR
721.5590.
PMN
Numbers
P
 
00
 
0333
and
P
 
00
 
0334
Chemical
name:
(
generic)
Salt
of
an
acrylate
copolymer.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substances
will
be
used
as
an
additive.
EPA
has
identified
concerns
for
lung
toxicity
and
lung
tumors
based
on
data
on
certain
high
molecular
weight
polymers.
Since
significant
worker
exposure
is
unlikely
as
inhalation
exposure
is
not
expected
for
the
uses
described
in
the
PMNs,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substances
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
uses
of
the
substances
in
a
solid
form
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substances
meet
the
concern
criteria
at
§
721.170(
b)(
3)(
ii).
Recommended
testing:
EPA
has
determined
that
a
90­
day
inhalation
toxicity
study
with
a
60­
day
holding
period
(
OPPTS
870.3465
test
guideline)
would
help
characterize
the
human
health
effects
of
the
PMN
substance.
Attention
should
be
given
to
the
lungs,
including
histopathology
of
the
lungs
(
inflamation,
epithelial
hyperplasia,
and
fibrosis),
bronchoalvelar
lavage
(
BAL)
analysis
for
markers
of
lung
injury,
and
lung
burden
analysis
for
clearance
of
the
test
material
(
EPA
 
748
 
R
 
96
 
001).
The
neurotoxicity
components
and
examination
of
organs
other
than
the
lungs
are
not
required.
CFR
citation:
40
CFR
721.338.
PMN
Number
P
 
00
 
0351
Chemical
name:
(
generic)
Aminohydroxy
sulfonaphthylazo­
disubstituted
phenyl
azo
benzene
carboxylate
salt.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
submitted
data
on
a
28­
day
study
in
rats
with
a
no
observed
adverse
effect
level
(
NOAEL)
of
25
mg/
kg/
day,
EPA
has
identified
concerns
for
liver
and
kidney
effects.
Additionally,
based
on
analogy
of
the
azo
reduction
product
of
the
PMN
substance,
EPA
has
concerns
for
carcinogenicity,
developmental
toxicity,
and
immunotoxicity.
Since
significant
worker
exposure
is
unlikely
as
inhalation
exposure
is
not
expected
for
the
use
described
in
the
PMN,
EPA
has
not
determined
that
manufacturing,
processing,
and
use
of
the
substance
as
described
in
the
PMN
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
use
of
the
substance
as
a
solid
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii),
(
b)(
3)(
iii),
and
(
b)(
1)(
i)(
D).
Recommended
testing:
EPA
has
determined
that
a
prenatal
developmental
toxicity
study
by
the
oral
route
in
two
species
(
OPPTS
870.3700
test
guideline)
and
an
Ames
assay
with
the
Prival
modification
and
a
concurrent
positive
control
(
OPPTS
870.5100
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.984.
PMN
Number
P
 
00
 
0353
Chemical
name:
(
generic)
Alkoxylated
aliphatic
diisocyanate
allyl
ether.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
an
additive
for
surface
coatings
and
for
plastics
and
plastic
surfaces.
Based
on
structural
analogy
to
esters
and
allylic
and
vinyl
ethers,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
9
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
PMN
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
chronic
toxicity
study
(
OPPTS
850.1400
test
guideline
(
public
draft)),
a
daphnid
chronic
toxicity
study
(
OPPTS
850.1300
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations,
dilution
water
hardness
less
than
180.0
mg/
L
as
CaC03.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
CFR
citation:
40
CFR
721.9952.
PMN
Numbers
P
 
00
 
0364
and
P
 
00
 
0365
Chemical
name:
(
generic)
Copper
complex
of
(
substituted
sulfonaphthyl
azo
substituted
phenyl)
disulfonaphthyl
azo,
amine
salt.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substances
will
be
used
as
described
in
the
PMNs.
Based
on
analogy
to
structurally
similar
substances,
EPA
has
identified
concerns
for
mutagenicity,
carcinogenicity,
and
developmental
toxicity.
Since
significant
worker
exposure
is
unlikely
as
inhalation
exposure
is
not
expected
for
the
uses
described
in
the
PMNs,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substances
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
use
of
the
substances
as
a
powder
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substances
meet
the
concern
criteria
at
§
721.170(
b)(
3)(
ii)
and
(
b)(
1)(
i)(
C).
Recommended
testing:
EPA
has
determined
that
a
prenatal
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00026
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15071
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
developmental
toxicity
study
by
the
oral
route
in
two
species
(
OPPTS
870.3700
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.2577.
PMN
Number
P
 
00
 
0420
Chemical
name:
(
generic)
Substituted
phenylazophenylazo
phenol.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
colorant.
Based
on
structural
analogy
to
phenols,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
1
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
water
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
Dilution
water
hardness
less
than
180.0
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.843
PMN
Number
P
 
00
 
0469
Chemical
name:
Glycine,
N­
(
carboxymethyl)­
N­
dodecyl­,
monosodium
salt.
CAS
number:
141321
 
68
 
8.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
surfactant.
Based
on
structural
analogy
to
alkyl
amphoteric
surfactants,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
30
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substance
is
not
released
to
surface
water
above
30
ppb,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manu­
facturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
environmental
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
water
above
30
ppb
may
cause
significant
adverse
environmental
effects.
Based
on
this
infor­
mation
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
the
following
acute
aquatic
toxicity
tests
would
help
to
characterize
the
environmental
effects:
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)).
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations,
dilution
water
total
organic
carbon
TOC
<
2.0
mg
TOC/
L
dilution
water
hardness
<
180.0
mg/
L
as
CaC03,
and
stock
solution
adjusted
to
pH
7.0.
CFR
citation:
40
CFR
721.3848.
PMN
Number
P
 
00
 
0490
Chemical
name:
(
generic)
Substituted
acrylamides
and
acrylic
acid
copolymer.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
delivery
substrate.
EPA
has
identified
concerns
for
lung
toxicity
and
carcinogenicity
if
the
substance
is
inhaled
based
on
data
for
certain
high
molecular
weight
polymers.
Since
significant
worker
exposure
is
unlikely
as
inhalation
exposure
to
worker
is
not
expected
for
the
use
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substances
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
domestic
manufacture,
or
processing
and
use
of
the
substance
in
a
powder
form
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii)
and
(
b(
1)(
i)(
C).
Recommended
testing:
EPA
has
determined
that
a
90­
day
inhalation
toxicity
study
with
a
60­
day
holding
period
(
OPPTS
870.3465
test
guideline)
would
help
characterize
the
human
health
effects
of
the
PMN
substance.
Attention
should
be
given
to
the
lungs,
including
histopathology
of
the
lungs
(
inflamation,
epithelial
hyperplasia,
and
fibrosis),
bronchoalvelar
lavage
(
BAL)
analysis
for
markers
of
lung
injury,
and
lung
burden
analysis
for
clearance
of
the
test
material
(
EPA
 
748
 
R
 
96
 
001).
The
neurotoxicity
components
and
examination
of
organs
other
than
the
lungs
are
not
required.
CFR
citation:
40
CFR
721.321.
PMN
Number
P
 
00
 
0542
Chemical
name:
(
generic)
Substituted
phenols
and
formaldehyde
polymer,
alkylated.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
resin
for
can
and
tube
coatings.
Based
on
structural
analogy
to
polyphenol
reaction
products,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
4
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
unlikely,
as
the
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
prevent
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
releases
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentration.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentration.
Dilution
water
hardness
<
180
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.3812.
PMN
Number
P
 
00
 
0559
Chemical
name:
(
generic)
Methylatedpara
rosaniline
salt
of
a
trisulfonated
triarylmethane
dye.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
colorant
for
inks.
EPA
has
identified
health
concerns
for
carcinogenicity
and
developmental
toxicity
based
on
analogy
to
gentian
violet.
Since
significant
worker
exposure
is
unlikely
when
the
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
processing
and
use
of
the
substance
may
present
a
unreasonable
risk.
EPA
has
determined
however,
that
domestic
manufacturing
could
result
in
exposures
which
may
cause
serious
health
effects.
Also,
based
on
analogy
to
cationic
dyes.
EPA
is
also
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
2
ppb
of
the
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00027
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15072
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substance
is
not
released
to
surface
water
above
2
ppb,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
environmental
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
water
above
2
ppb
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170
(
b)(
1)(
i)(
C),
(
b)(
3)(
ii),
and
(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
the
following
acute
aquatic
toxicity
tests
would
help
to
characterize
the
environmental
effects:
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)).
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations,
dilution
water
total
organic
carbon
TOC
<
2.0
mg
TOC/
L.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentration.
Dilution
water
hardness
<
180.0
mg/
L
as
CaC03.
EPA
has
also
determined
that
a
prenatal
developmental
toxicity
study
by
the
oral
route
in
two­
species
(
OPPTS
870.3700
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.9520.
PMN
Number
P
 
00
 
0618
Chemical
name:
(
generic)
Substituted
hydroxyalkane
acetate.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
EPA
has
concerns
for
liver
toxicity,
kidney
toxicity,
and
developmental
toxicity
based
on
a
28­
day
subchronic
inhalation
study
in
rats
and
a
developmental
toxicity
study
in
rats
for
an
analog
of
the
PMN
material;
EPA
identified
concerns
for
neurotoxicity
and
carcinogenicity
based
on
analog
data.
Since
significant
worker
exposure
is
unlikely
as
inhalation
exposure
is
not
expected
for
the
use
described
in
the
PMN,
EPA
has
not
determined
that
manufacturing,
processing,
and
use
of
the
substance
as
described
in
the
PMN
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
use
of
the
substance
other
than
as
described
in
the
PMN
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170
(
b)(
3)(
i),
(
b)(
3)(
ii),
and
(
b)(
1)(
i)(
C).
Recommended
testing:
EPA
has
determined
that
a
prenatal
developmental
toxicity
study
by
the
oral
route
in
two
species
(
OPPTS
870.3700
test
guideline)
and
a
90­
day
inhalation
toxicity
study
with
a
60­
day
holding
period
(
OPPTS
870.3465
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.532.
PMN
Number
P
 
00
 
0626
Chemical
name:
(
generic)
Acrylate
of
polymer
based
on
isophorone
diisocyanate.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
an
additive
for
inks
and
coatings.
Based
on
structural
analogy
to
acrylates,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
1
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substance
is
not
released
to
surface
water
above
3
ppb,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
environmental
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
water
above
3
ppb
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
the
following
acute
aquatic
toxicity
tests
would
help
to
characterize
the
environmental
effects:
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)).
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
Dilution
water
hardness
<
180.0
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.463.
PMN
Number
P
 
00
 
0637
Chemical
name:
Methylium,
triphenyl­,
tetrakis(
pentafluorophenyl)
borate
(
l­).
CAS
number:
136040
 
19
 
2.
Basis
for
action:
The
use
of
the
substance
is
as
described
in
the
PMN.
Based
on
structural
analogy
to
organoborates,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
1
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
Dilution
water
hardness
less
than
180.0
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.5454.
PMN
Number
P
 
00
 
0638
Chemical
name:
(
generic)
Alkali
metal
salt
of
halogenated
organoborate.
CAS
number:
Not
available.
Basis
for
action:
The
use
of
the
substance
is
as
described
in
the
PMN.
Based
on
structural
analogy
to
organoborates,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
3
ppb
of
the
PMN
substances
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00028
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15073
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
Dilution
water
hardness
less
than
180.0
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.5452.
PMN
Number
P
 
00
 
0691
Chemical
name:
Amides,
from
ammonium
hydroxide
­
maleic
anhydride
polymer
and
hydrogenated
tallow
alkyl
amines,
sodium
salts,
compds.
with
ethanolamine.
CAS
number:
208408
 
03
 
1.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
structural
analogy
to
anionic
surfactants.
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
80
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substance
is
not
released
to
surface
water
above
80
ppb,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
other
uses
of
the
substance
resulting
in
release
to
surface
waters
above
80
ppb
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
the
following
acute
aquatic
toxicity
tests
would
help
to
characterize
the
environmental
effects:
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)).
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
Dilution
water
hardness
<
180.0
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.6183.
PMN
Number
P
 
00
 
0698
Chemical
name:
(
generic)
Lithium
salt
of
a
sulfophenyl
azo
phenyl
azo
disulfostilbene.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
analogy
to
structurally
similar
substance,
EPA
has
identified
concerns
for
liver
toxicity,
developmental
toxicity,
neurotoxicity,
and
blood
toxicity
for
the
aromatic
amine
azo
reduction
product.
Since
significant
worker
exposure
is
unlikely
as
inhalation
exposure
is
not
expected
for
the
uses
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
use
of
the
substance
as
a
solid
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
iii).
Recommended
testing:
EPA
has
determined
that
a
prenatal
developmental
toxicity
study
by
the
oral
route
in
two
species
(
OPPTS
870.3700
test
guideline)
and
a
90­
day
subchronic
oral
toxicity
study
in
rodents
(
OPPTS
870.3100
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.9538.
PMN
Number
P
 
00
 
0738
Chemical
name:
Formaldehyde,
reaction
products
with
1,3­
benzenedimethanamine
and
bisphenol
A.
CAS
number:
259871
 
68
 
6.
Basis
for
action:
The
PMN
substance
will
be
used
as
coatings
for
railcars
and
marine
vessels.
Based
on
structural
analogy
to
phenols
and
aliphatic
amines,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
20
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
releases
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
These
tests
should
be
conducted
with
the
static
methods
and
nominal
concentrations,
dilution
water
total
organic
carbon
TOC
<
2.0
mg
TOC/
L
dilution
water
hardness
<
180.0
mg/
L
as
CaC03,
and
stock
solution
adjusted
to
pH
7.0.
EPA
has
also
determined
that
an
activated
sludge
isotherm
test
(
OPPTS
835.1110
test
guideline)
would
help
to
characterize
the
environmental
fate
of
the
PMN
substance.
CFR
citation:
40
CFR
721.3805.
PMN
Number
P
 
00
 
0789
Chemical
name:
1,4­
Benzedicarboxylic
acid,
dimethyl
ester,
polymer
with
1,4
­
butanediol,
cyclized.
CAS
number:
263244
 
54
 
8.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
curable
thermoplastic
resin.
EPA
has
identified
health
and
environmental
concerns
because
the
substance
is
potentially
a
persistent,
bioaccumulative,
and
toxic
(
PBT)
chemical,
EPA
estimates
that
the
PMN
substance
will
persist
in
the
environment
more
than
two
months
and
estimates
a
bioaccumulation
factor
of
greater
than
or
equal
to
1,000.
Also
based
on
structural
analogy
to
esters,
EPA
expects
toxicity
to
aquatic
organisms
at
surface
water
concentrations
as
low
as
9
ppb.
Since
significant
environmental
exposure
is
not
expected
as
the
substance
is
not
released
to
surface
waters,
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
water
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
the
results
of
the
tiered
testing
as
described
in
the
New
Chemicals
Program's
PBT
Policy
Statement
(
63
FR
60194;
November
4,
1999)
(
FRL
 
6097
 
7)
would
help
to
characterized
the
properties
of
the
substance.
EPA
has
also
determined
that
the
following
aquatic
toxicity
tests:
a
fish
chronic
toxicity
study
(
OPPTS
850.1400
test
guideline
(
public
draft)),
a
daphnid
chronic
toxicity
study
(
OPPTS
850.1300
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
Dilution
water
hardness
<
180.0
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.990.
PMN
Number
P
 
00
 
0803
Chemical
name:
(
generic)
2,7­
Naphthalenedisulfonic
acid,
5­[[
4­
chloro­
6­[
substituted]
amino]­
1,3,5­

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00029
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15074
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
triazin­
2­
yl]
amino]­
4­
hydroxy­
3­[(
1­
sulfo­
2­
naphthalenyl)
azo]­,
trisodium
salt.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
textile
dye.
EPA
has
identified
health
concerns
for
mutagenicity
and
developmental
toxicity
based
on
one
of
the
substituents
on
an
azo
reduction
product.
Since
significant
worker
exposure
is
unlikely
when
the
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
domestic
manufacture
could
result
in
exposures
which
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
iii).
Recommended
testing:
EPA
has
determined
that
a
prenatal
developmental
toxicity
study
by
the
oral
route
in
rats
(
OPPTS
870.3700
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.5262.
PMN
Number
P
 
00
 
0806
Chemical
name:
1,3,6­
Naphthalenetrisulfonic
acid,
7­[[
2­
[(
aminocarbonyl)
amino]­
4­[[
4­[[
2­[
2­
(
ethenylsulfonyl)
ethoxy]
ethyl]
amino]­
6­
fluoro­
1,3,5­
triazin­
2­
yl]
amino]
phenyl]
azo],
trisodium
salt.
CAS
number:
106359
 
91
 
5.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
textile
dye.
Based
on
submitted
test
data,
EPA
has
identified
health
concerns
for
mutagenicity,
dermal
sensitization
and
possible
irreversible
cornea
staining;
developmental
toxicity
and
carcinogenicity
based
on
one
of
the
substituents
on
an
azo
reduction
product.
Since
significant
worker
exposure
is
unlikely
when
the
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
domestic
manufacture
could
result
in
exposures
which
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
i),
(
b)(
l)(
i)(
D),
and
(
b)(
3)(
iii).
Recommended
testing:
EPA
has
determined
that
a
prenatal
developmental
toxicity
study
by
the
oral
route
in
rats
(
OPPTS
870.3700
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
CFR
citation:
40
CFR
721.5260.
PMN
Number
P
 
00
 
0816
Chemical
name:
(
generic)
Alkyl
dialkylamino
phenylsulfonyl
alkenoate.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
test
data
for
structurally
similar
compounds,
EPA
has
identified
health
concerns
for
kidney
and
liver
toxicity.
Since
significant
worker
exposure
is
unlikely
when
the
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
domestic
manufacture
could
result
in
exposures
which
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
i).
Also,
based
on
structural
analogy
to
aliphatic
amines,
acrylates,
and
allylic
and
vinyl
sulfones,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
1
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
90­
day
subchronic
oral
study
in
rats
(
OPPTS
870.3100)
would
help
characterize
the
human
health
effects
of
the
PMN
substance.
Also
the
following
aquatic
toxicity
test
would
help
characterize
the
environmental
effects
of
the
PMN
substance:
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)).
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations,
dilution
water
total
organic
carbon
TOC
<
2.0
mg
TOC/
L
dilution
water
hardness
<
180.0
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.648.
PMN
Number
P
 
00
 
0827
Chemical
name:
1­
propanol,
3­
propoxy­
.
CAS
number:
4161
 
22
 
2.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
EPA
has
identified
health
concerns
for
liver
toxicity
based
on
submitted
test
data
and
neurotoxicity
based
on
the
solvent
properties
of
the
substance.
Since
significant
worker
exposure
is
unlikely,
when
the
substance
is
used
with
protective
equipment
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
use
of
the
substance
other
than
as
described
in
the
PMN
including
handling
the
material
without
the
use
of
impervious
gloves
could
result
in
exposures
which
may
cause
serious
health
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
i)
and
(
b)(
3)(
ii).
Recommended
testing:
EPA
has
determined
that
a
90­
day
subchronic
oral
study
(
OPPTS
870.3100
test
guideline),
and
a
prenatal
developmental
toxicity
study
(
OPPTS
870.3700
test
guideline)
would
help
to
characterize
the
health
effects
of
the
substance.
CFR
citation:
40
CFR
721.525.
PMN
Number
P
 
00
 
0922
Chemical
name:
Borate(
1­),
tris(
acetato­
.
kappa.
O)
hydro­,
sodium,
(
T­
4)­.
CAS
number:
56553
 
60
 
7.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
structural
analogy
to
other
boron
compounds,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
300
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substance
is
not
released
to
surface
water
above
300
ppb,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
water
above
300
ppb
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170
(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00030
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15075
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
Dilution
water
hardness
less
than
180.0
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.1880.
PMN
Number
P
 
00
 
0993
Chemical
name:
(
generic)
Substituted
6,6'­(
1­
methylethylidene)
bis[
3,4­
dihydro­
3­
phenyl­
1,3­
benzoxazine].
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
resin
for
structural
composites
and
electronic
laminates.
EPA
has
identified
health
and
environmental
concerns
because
the
substance
is
potentially
a
PBT
chemical.
Since
significant
environmental
exposure
is
not
expected,
as
the
substance
is
not
released
to
surface
waters,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
releases
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
the
results
of
the
tiered
testing
as
described
in
the
New
Chemicals
Program's
PBT
Category
(
63
FR
60194;
November
4,
1999)
would
help
to
characterized
the
properties
of
the
substance.
EPA
has
also
determined
that
the
results
of
the
following
aquatic
toxicity
tests:
a
fish
chronic
toxicity
study
(
OPPTS
850.1400
test
guideline
(
public
draft)),
a
daphnid
chronic
toxicity
study
(
OPPTS
850.1300
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft)),
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations,
dilution
water
hardness
<
180.0
mg/
L
as
CaC03.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations.
CFR
citation:
40
CFR
721.1767
PMN
Number
P
 
00
 
1086
Chemical
name:
(
generic)
Silyl
amine,
potassium
salt.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
structural
analogy
to
aliphatic
amines,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
10
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substance
is
not
released
to
surface
waters
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170
(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentrations.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentrations,
dilution
water
total
organic
carbon
TOC
<
2.0
mg
TOC/
L
dilution
water
hardness
<
180.0
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.638.
PMN
Number
P
 
00
 
1087
Chemical
name:
(
generic)
Di­
alkyl
borane.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
structural
analogy
to
organoborane
compounds,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
200
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
as
the
PMN
substance
is
not
released
to
surface
water
above
200
ppb,
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
above
200
ppb
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentration.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentration.
Dilution
water
hardness
<
180
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.1852.
PMN
Number
P
 
00
 
1089
Chemical
name:
(
generic)
Alkali
metal
alkyl
borohydride.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
described
in
the
PMN.
Based
on
structural
analogy
to
organoborane
compounds,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
300
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected,
as
the
substance
is
not
released
to
surface
waters
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
other
uses
of
the
substance
resulting
in
release
to
surface
waters
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentration.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentration.
Dilution
water
hardness
<
180
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.1878.
PMN
Number
P
 
00
 
1132
Chemical
name:
(
generic)
Siloxanes
and
silicones,
aminoalkyl,
fluorooctyl,
hydroxy­
terminated
salt.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
in
anti­
graffiti
systems
as
described
in
the
PMN.
Based
on
structural
analogy
to
perfluoro
alkyl
polycationic
polymers,
EPA
has
identified
health
concerns
for
lung
toxicity
from
inhalation
exposure.
Since
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00031
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15076
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
significant
worker
exposure
is
unlikely
when
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
cause
significant
adverse
effects.
EPA
has
determined,
however,
that
use
of
the
PMN
substance
other
than
as
described
in
the
PMN
could
result
in
exposures
which
may
cause
serious
health
effects.
In
addition,
EPA
has
identified
health
concerns
for
potential
incineration
products
for
the
PMN
substance
based
on
analogy
to
perfluorinated
octane
sulfonate
(
PFOS)
and
perfluorinated
octanoic
acid
(
PFOA).
These
incineration
products
are
PBT.
Based
on
this
information,
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii).
Recommended
testing:
EPA
has
determined
that
a
90­
day
inhalation
toxicity
study
in
rats
with
a
60­
day
holding
period
(
OPPTS
870.3465
test
guideline)
would
help
characterize
the
human
health
effects
of
the
PMN
substance.
Special
attention
should
be
given
to
histopathology
(
inflammation
and
cell
proliferation)
of
the
lung
tissues
and
to
various
parameters
of
the
bronchoalveolar
lavage
fluid
(
BALF),
e.
g.,
marker
enzyme
activities,
total
protein
content,
total
cell
count,
cell
differential,
and
cell
viability.
It
is
not
necessary
to
look
at
internal
organs.
The
Agency
has
also
determined
that
the
following
tests
would
help
characterize
fate
and
ecotoxicity
of
the
PMN
substance:
A
Decomposition
Kinetics
by
Thermogravimeter
(
ASTM
E1641),
a
Compositional
Analysis
by
Thermogravimeter
(
ASTM
E1131),
and
a
Laboratory
``
Burn''
test
­
protocol
to
be
agreed
upon
by
EPA
and
the
Company.
The
purpose
of
this
test
is
to
determine
the
disposition
of
the
material
and
to
identify
degradates,
especially
the
presence
of
components
that
can
lead
to
the
formation
of
perfluofo
alkyl
carboxylic
acid
after
burning
or
incineration.
CFR
citation:
40
CFR
721.9502.
PMN
Number
P
 
00
 
1195
Chemical
name:
Xanthylium,
9­(
2­
(
ethoxycarbonyl)
phenyl)­
3,6­
bis(
ethylamino)­
2,7­
dimethyl­,
ethyl
sulfate.
CAS
number:
26694
 
69
 
9.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
dye
for
complex
basic
dye
pigment
manufacture.
Based
on
submitted
test
data
for
an
analog,
EPA
has
identified
health
concerns
for
toxic
effects
to
the
liver
and
heart.
Since
significant
worker
exposure
is
unlikely
when
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
domestic
manufacture
or
use
of
the
PMN
substance
other
than
as
an
intermediate
could
result
in
serious
health
effects.
Also,
based
on
structural
analogy
to
cationic
dyes,
EPA
is
concerned
that
toxicity
to
aquatic
organisms
may
occur
at
a
concentration
as
low
as
2
ppb
of
the
PMN
substance
in
surface
waters.
Since
significant
environmental
exposure
is
not
expected
when
the
PMN
substance
is
used
as
described
in
the
PMN,
EPA
has
not
determined
that
the
proposed
use
of
the
substance
may
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
use
of
the
substance
other
than
as
described
in
the
PMN
may
cause
significant
adverse
environmental
effects.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii)
and
(
b)(
4)(
ii).
Recommended
testing:
EPA
has
determined
that
an
acute
oral
toxicity
study
(
40
CFR
part
799.9110(
d)(
1)(
i)(
A)),
a
Salmonella
typhimurium
reverse
mutation
assay
(
OPPTS
870.5100
test
guideline),
a
28­
day
oral
toxicity
study
Organization
for
Economic
Cooperation
and
Development
(
OECD)
guideline
no.
407
or
OPPTS
870.3050
test
guideline),
and
an
in
vivo
mammalian
cytogenetics
test
by
the
intraperitoneal
(
i.
p.)
route:
micronucleus
assay
(
OPPTS
870.5395
test
guideline)
would
help
to
characterize
the
human
health
effects
of
the
PMN
substance.
EPA
has
also
determined
that
a
fish
acute
toxicity
study
(
OPPTS
850.1075
test
guideline
(
public
draft)),
a
daphnid
acute
toxicity
study
(
OPPTS
850.1010
test
guideline
(
public
draft)),
and
an
algal
acute
toxicity
study
(
OPPTS
850.5400
test
guideline
(
public
draft))
would
help
to
characterize
the
environmental
effects
of
the
PMN
substance.
The
fish
and
daphnid
tests
should
be
conducted
with
flow­
through
methods
and
measured
concentration.
The
algal
test
should
be
conducted
with
static
methods
and
measured
concentration.
Dilution
water
hardness
<
180
mg/
L
as
CaC03.
CFR
citation:
40
CFR
721.2465.
PMN
Number
P
 
01
 
0432
Chemical
name:
(
generic)
Bis
heterocyclic
phenylene
derivative.
CAS
number:
Not
available.
Basis
for
action:
The
PMN
substance
will
be
used
as
a
reactive
modifier
for
polymeric
substances.
EPA
has
identified
health
concerns
for
neurotoxicity,
developmental
toxicity,
mutagenicity,
carcinogenicity,
lung
and
liver
toxicity,
and
sensitization
based
on
test
data.
Since
significant
worker
exposure
is
unlikely
because
there
would
not
be
significant
inhalation
exposure
for
the
use
identified
in
the
PMN,
EPA
has
not
determined
that
the
proposed
manufacturing,
processing,
and
use
of
the
substance
as
described
in
the
PMN
present
an
unreasonable
risk.
EPA
has
determined,
however,
that
an
increase
in
production
volume
over
that
described
in
the
PMN
could
result
in
significant
exposure
to
human
health.
Based
on
this
information
the
PMN
substance
meets
the
concern
criteria
at
§
721.170(
b)(
3)(
ii)
and
(
b)(
1)(
i)(
A).
Recommended
testing:
EPA
has
determined
that
a
mouse
micronucleus
test
by
the
i.
p.
route
(
OPPTS
870.5395
test
guideline)
and
a
28­
day
oral
toxicity
in
rats
OECD
guideline
number
407
or
(
OPPTS
870.3050)
with
a
Functional
Observational
Battery
(
FOB)
would
help
to
characterize
the
health
effects
of
the
substance.
If
the
above
tests
indicate
a
health
concern,
then
the
following
tests
may
be
necessary
to
qualify
the
potential
health
effects:
a
90­
day
subchronic
oral
study
in
rats
(
OPPT
870.3100
test
guideline),
a
prenatal
development
toxicity
study
by
oral
route
in
two
species
(
OPPTS
870.3700
test
guideline),
a
reproduction
and
fertility
effects
(
OPPTS
870.3800
test
guideline),
and
a
carcinogenicity
study
(
OPPTS
870.4200
test
guideline).
CFR
citation:
40
CFR
721.5925.

IV.
Objectives
and
Rationale
of
the
Rule
During
review
of
the
PMNs
submitted
for
the
chemical
substances
that
are
subject
to
this
SNUR,
EPA
concluded
that
for
3
of
the
62
substances,
regulation
was
warranted
under
section
5(
e)
of
TSCA,
pending
the
development
of
information
sufficient
to
make
reasoned
evaluations
of
the
health
or
environmental
effects
of
the
substances.
The
basis
for
such
findings
is
outlined
in
Unit
III.
Based
on
these
findings,
TSCA
section
5(
e)
consent
orders
requiring
the
use
of
appropriate
exposure
controls
were
negotiated
with
the
PMN
submitters;
the
SNUR
provisions
for
these
substances
designated
herein
are
consistent
with
the
provisions
of
the
TSCA
section
5(
e)
consent
orders.
In
the
other
59
cases
for
which
the
proposed
uses
are
not
regulated
under
a
TSCA
section
5(
e)
consent
order,
EPA
determined
that
one
or
more
of
the
criteria
of
concern
established
at
40
CFR
721.170
were
met.
EPA
is
issuing
this
SNUR
for
specific
chemical
substances
which
have
undergone
premanufacture
review
to
ensure
that:
1.
EPA
will
receive
notice
of
any
company's
intent
to
manufacture,
import,
or
process
a
listed
chemical
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00032
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15077
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
substance
for
a
significant
new
use
before
that
activity
begins.
2.
EPA
will
have
an
opportunity
to
review
and
evaluate
data
submitted
in
a
SNUR
notice
before
the
notice
submitter
begins
manufacturing,
importing,
or
processing
a
listed
chemical
substance
for
a
significant
new
use.
3.
When
necessary,
to
prevent
unreasonable
risks,
EPA
will
be
able
to
regulate
prospective
manufacturers,
importers,
or
processors
of
a
listed
chemical
substance
before
a
significant
new
use
of
that
substance
occurs.
4.
All
manufacturers,
importers,
and
processors
of
the
same
chemical
substance
which
is
subject
to
a
TSCA
section
5(
e)
consent
order
are
subject
to
similar
requirements.
Issuance
of
a
SNUR
for
a
chemical
substance
does
not
signify
that
the
substance
is
listed
on
the
TSCA
Inventory.
Manufacturers,
importers,
and
processors
are
responsible
for
ensuring
that
a
new
chemical
substance
subject
to
a
final
SNUR
is
listed
on
the
TSCA
Inventory.

V.
Direct
Final
Procedures
EPA
is
issuing
these
SNURs
as
a
direct
final
rule,
as
described
in
40
CFR
721.160(
c)(
3)
and
721.170(
d)(
4).
In
accordance
with
40
CFR
721.160(
c)(
3)(
ii),
this
rule
will
be
effective
May
27,
2003,
unless
EPA
receives
a
written
notice
by
April
28,
2003
that
someone
wishes
to
make
adverse
or
critical
comments
on
EPA's
action.
If
EPA
receives
such
a
notice,
EPA
will
publish
a
document
to
withdraw
the
direct
final
SNUR
for
the
specific
substance
to
which
the
adverse
or
critical
comments
apply.
EPA
will
then
propose
a
SNUR
for
the
specific
substance
providing
a
30­
day
comment
period.
This
action
establishes
SNURs
for
a
number
of
chemical
substances.
Any
person
who
submits
a
notice
of
intent
to
submit
adverse
or
critical
comments
must
identify
the
substance
and
the
new
use
to
which
it
applies.
EPA
will
not
withdraw
a
SNUR
for
a
substance
not
identified
in
a
notice.

VI.
Test
Data
and
Other
Information
EPA
recognizes
that
section
5
of
TSCA
does
not
require
developing
any
particular
test
data
before
submission
of
a
SNUN.
Persons
are
required
only
to
submit
test
data
in
their
possession
or
control
and
to
describe
any
other
data
known
to
or
reasonably
ascertainable
by
them.
In
cases
where
a
TSCA
section
5(
e)
consent
order
requires
or
recommends
certain
testing,
Unit
III.
lists
those
recommended
tests.
However,
EPA
has
established
production
limits
in
the
TSCA
section
5(
e)
consent
orders
for
several
of
the
substances
regulated
under
this
rule,
in
view
of
the
lack
of
data
on
the
potential
health
and
environmental
risks
that
may
be
posed
by
the
significant
new
uses
or
increased
exposure
to
the
substances.
These
production
limits
cannot
be
exceeded
unless
the
PMN
submitter
first
submits
the
results
of
toxicity
tests
that
would
permit
a
reasoned
evaluation
of
the
potential
risks
posed
by
these
substances.
Under
recent
consent
orders,
each
PMN
submitter
is
required
to
submit
each
study
at
least
14
weeks
(
earlier
consent
orders
required
submissions
at
least
12
weeks)
before
reaching
the
specified
production
limit.
Listings
of
the
tests
specified
in
the
TSCA
section
5(
e)
consent
orders
are
included
in
Unit
III.
The
SNURs
contain
the
same
production
volume
limits
as
the
consent
orders.
Exceeding
these
production
limits
is
defined
as
a
significant
new
use.
The
recommended
studies
may
not
be
the
only
means
of
addressing
the
potential
risks
of
the
substance.
However,
SNUNs
submitted
for
significant
new
uses
without
any
test
data
may
increase
the
likelihood
that
EPA
will
take
action
under
TSCA
section
5(
e),
particularly
if
satisfactory
test
results
have
not
been
obtained
from
a
prior
submitter.
EPA
recommends
that
potential
SNUN
submitters
contact
EPA
early
enough
so
that
they
will
be
able
to
conduct
the
appropriate
tests.
SNUN
submitters
should
be
aware
that
EPA
will
be
better
able
to
evaluate
SNUNs
which
provide
detailed
information
on:
1.
Human
exposure
and
environmental
release
that
may
result
from
the
significant
new
use
of
the
chemical
substances.
2.
Potential
benefits
of
the
substances.
3.
Information
on
risks
posed
by
the
substances
compared
to
risks
posed
by
potential
substitutes.

VII.
Procedural
Determinations
EPA
is
establishing
through
this
rule
some
significant
new
uses
which
have
been
claimed
as
CBI
subject
to
Agency
confidentiality
regulations
at
40
CFR
part
2.
EPA
is
required
to
keep
this
information
confidential
to
protect
the
CBI
of
the
original
PMN
submitter.
EPA
promulgated
a
procedure
to
deal
with
the
situation
where
a
specific
significant
new
use
is
CBI.
This
procedure
appears
in
40
CFR
721.1725(
b)(
1)
and
is
similar
to
that
in
§
721.11
for
situations
where
the
chemical
identity
of
the
substance
subject
to
a
SNUR
is
CBI.
This
procedure
is
cross­
referenced
in
each
of
these
SNURs.
A
manufacturer
or
importer
may
request
EPA
to
determine
whether
a
proposed
use
would
be
a
significant
new
use
under
this
rule.
Under
the
procedure
incorporated
from
§
721.1725(
b)(
1),
a
manufacturer
or
importer
must
show
that
it
has
a
bona
fide
intent
to
manufacture
or
import
the
substance
and
must
identify
the
specific
use
for
which
it
intends
to
manufacture
or
import
the
substance.
If
EPA
concludes
that
the
person
has
shown
a
bona
fide
intent
to
manufacture
or
import
the
substance,
EPA
will
tell
the
person
whether
the
use
identified
in
the
bona
fide
submission
would
be
a
significant
new
use
under
the
rule.
Since
most
of
the
chemical
identities
of
the
substances
subject
to
these
SNURs
are
also
CBI,
manufacturers
and
processors
can
combine
the
bona
fide
submission
under
the
procedure
in
§
721.1725(
b)(
1)
with
that
under
§
721.11
into
a
single
step.
If
a
manufacturer
or
importer
is
told
that
the
production
volume
identified
in
the
bona
fide
submission
would
not
be
a
significant
new
use,
i.
e.
it
is
below
the
level
that
would
be
a
significant
new
use,
that
person
can
manufacture
or
import
the
substance
as
long
as
the
aggregate
amount
does
not
exceed
that
identified
in
the
bona
fide
submission
to
EPA.
If
the
person
later
intends
to
exceed
that
volume,
a
new
bona
fide
submission
would
be
necessary
to
determine
whether
that
higher
volume
would
be
a
significant
new
use.
EPA
is
considering
whether
to
adopt
a
special
procedure
for
use
when
CBI
production
volume
is
designated
as
a
significant
new
use.
Under
such
a
procedure,
a
person
showing
a
bona
fide
intent
to
manufacture
or
import
the
substance,
under
the
procedure
described
in
§
721.11,
would
automatically
be
informed
of
the
production
volume
that
would
be
a
significant
new
use.
Thus,
the
person
would
not
have
to
make
multiple
bona
fide
submissions
to
EPA
for
the
same
substance
to
remain
in
compliance
with
the
SNUR,
as
could
be
the
case
under
the
procedures
in
§
721.1725(
b)(
1).

VIII.
Applicability
of
Rule
to
Uses
Occurring
Before
Effective
Date
of
the
Final
Rule
To
establish
a
significant
``
new''
use,
EPA
must
determine
that
the
use
is
not
ongoing.
The
chemical
substances
subject
to
this
rule
have
recently
undergone
premanufacture
review.
TSCA
section
5(
e)
consent
orders
have
been
issued
for
3
substances
and
notice
submitters
are
prohibited
by
the
TSCA
section
5(
e)
consent
orders
from
undertaking
activities
which
EPA
is
designating
as
significant
new
uses.
In
cases
where
EPA
has
not
received
an
NOC
and
the
substance
has
not
been
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00033
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15078
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
added
to
the
Inventory,
no
other
person
may
commence
such
activities
without
first
submitting
a
PMN.
For
substances
for
which
an
NOC
has
not
been
submitted
at
this
time,
EPA
has
concluded
that
the
uses
are
not
ongoing.
However,
EPA
recognizes
in
cases
when
chemical
substances
identified
in
this
SNUR
are
added
to
the
Inventory
prior
to
the
effective
date
of
the
rule,
the
substances
may
be
manufactured,
imported,
or
processed
by
other
persons
for
a
significant
new
use
as
defined
in
this
rule
before
the
effective
date
of
the
rule.
However,
41
of
the
62
substances
contained
in
this
rule
have
CBI
chemical
identities,
and
since
EPA
has
received
a
limited
number
of
post­
PMN
bona
fide
submissions,
the
Agency
believes
that
it
is
highly
unlikely
that
any
of
the
significant
new
uses
described
in
the
following
regulatory
text
are
ongoing.
As
discussed
in
the
Federal
Register
of
April
24,
1990,
EPA
has
decided
that
the
intent
of
section
5(
a)(
1)(
B)
of
TSCA
is
best
served
by
designating
a
use
as
a
significant
new
use
as
of
the
date
of
publication
rather
than
as
of
the
effective
date
of
the
rule.
Thus,
persons
who
begin
commercial
manufacture,
import,
or
processing
of
the
substances
regulated
through
this
SNUR
will
have
to
cease
any
such
activity
before
the
effective
date
of
this
rule.
To
resume
their
activities,
these
persons
would
have
to
comply
with
all
applicable
SNUR
notice
requirements
and
wait
until
the
notice
review
period,
including
all
extensions,
expires.
EPA
has
promulgated
provisions
to
allow
persons
to
comply
with
this
SNUR
before
the
effective
date.
If
a
person
were
to
meet
the
conditions
of
advance
compliance
under
§
721.45(
h),
the
person
would
be
considered
to
have
met
the
requirements
of
the
final
SNUR
for
those
activities.
If
persons
who
begin
commercial
manufacture,
import,
or
processing
of
the
substance
between
publication
and
the
effective
date
of
the
SNUR
do
not
meet
the
conditions
of
advance
compliance,
they
must
cease
that
activity
before
the
effective
date
of
the
rule.
To
resume
their
activities,
these
persons
would
have
to
comply
with
all
applicable
SNUR
notice
requirements
and
wait
until
the
notice
review
period,
including
all
extensions,
expires.

IX.
Economic
Analysis
EPA
has
evaluated
the
potential
costs
of
establishing
SNUN
requirements
for
potential
manufacturers,
importers,
and
processors
of
the
chemical
substance
subject
to
this
rule.
EPA's
complete
economic
analysis
is
available
in
the
official
public
docket.
X.
Statutory
and
Executive
Order
Reviews
Under
Executive
Order
12866,
entitled
Regulatory
Planning
and
Review
(
58
FR
51735,
October
4,
1993),
the
Office
of
Management
and
Budget
(
OMB)
has
determined
that
proposed
or
final
SNURs
are
not
a
``
significant
regulatory
action''
subject
to
review
by
OMB,
because
they
do
not
meet
the
criteria
in
section
3(
f)
of
the
Executive
Order.
According
to
the
Paperwork
Reduction
Act
(
PRA),
44
U.
S.
C.
3501
et
seq.,
an
Agency
may
not
conduct
or
sponsor,
and
a
person
is
not
required
to
respond
to
a
collection
of
information
that
requires
OMB
approval
under
the
PRA,
unless
it
has
been
approved
by
OMB
and
displays
a
currently
valid
OMB
control
number.
The
OMB
control
numbers
for
EPA's
regulations
in
title
40
of
the
CFR,
after
appearing
in
the
Federal
Register,
are
listed
in
40
CFR
part
9,
and
included
on
the
related
collection
instrument
or
form,
if
applicable.
The
information
collection
requirements
related
to
this
action
have
already
been
approved
by
OMB
pursuant
to
the
PRA
under
OMB
control
number
2070
 
0012
(
EPA
ICR
No.
574).
This
action
does
not
impose
any
burden
requiring
additional
OMB
approval.
If
an
entity
were
to
submit
a
SNUN
to
the
Agency,
the
annual
burden
is
estimated
to
average
between
30
and
170
hours
per
response.
This
burden
estimate
includes
the
time
needed
to
review
instructions,
search
existing
data
sources,
gather
and
maintain
the
data
needed,
and
complete,
review,
and
submit
the
required
SNUN.
Send
any
comments
about
the
accuracy
of
the
burden
estimate,
and
any
suggested
methods
for
minimizing
respondent
burden,
including
through
the
use
of
automated
collection
techniques,
to
the
Director,
Collection
Strategies
Division,
Office
of
Environmental
Information
(
2822T),
Environmental
Protection
Agency,
1200
Pennsylvania
Ave.,
NW.,
Washington,
DC
20460
 
0001.
Please
remember
to
include
the
OMB
control
number
in
any
correspondence,
but
do
not
submit
any
completed
forms
to
this
address.
Pursuant
to
section
605(
b)
of
the
Regulatory
Flexibility
Act
(
RFA)
(
5
U.
S.
C.
601
et
seq.),
the
Agency
hereby
certifies
that
promulgation
of
this
SNUR
will
not
have
a
significant
adverse
economic
impact
on
a
substantial
number
of
small
entities.
The
rationale
supporting
this
conclusion
is
as
follows.
A
SNUR
applies
to
any
person
(
including
small
or
large
entities)
who
intends
to
engage
in
any
activity
described
in
the
rule
as
a
``
significant
new
use.''
By
definition
of
the
word
``
new,''
and
based
on
all
information
currently
available
to
EPA,
it
appears
that
no
small
or
large
entities
presently
engage
in
such
activity.
Since
a
SNUR
only
requires
that
any
person
who
intends
to
engage
in
such
activity
in
the
future
must
first
notify
EPA
by
submitting
a
SNUN,
no
economic
impact
will
even
occur
until
someone
decides
to
engage
in
those
activities.
Although
some
small
entities
may
decide
to
conduct
such
activities
in
the
future,
EPA
cannot
presently
determine
how
many,
if
any,
there
may
be.
However,
EPA's
experience
to
date
is
that,
in
response
to
the
promulgation
of
over
900
SNURs,
the
Agency
has
received
fewer
than
25
SNUNs.
Of
those
SNUNs
submitted,
none
appear
to
be
from
small
entities
in
response
to
any
SNUR.
In
addition,
the
estimated
reporting
cost
for
submission
of
a
SNUN
(
see
Unit
IX.),
are
minimal
regardless
of
the
size
of
the
firm.
Therefore,
EPA
believes
that
the
potential
economic
impact
of
complying
with
this
SNUR
are
not
expected
to
be
significant
or
adversely
impact
a
substantial
number
of
small
entities.
In
a
SNUR
that
published
on
June
2,
1997
(
62
FR
29684)
(
FRL
 
5597
 
1),
the
Agency
presented
it's
general
determination
that
proposed
and
final
SNURs
are
not
expected
to
have
a
significant
economic
impact
on
a
substantial
number
of
small
entities,
which
was
provided
to
the
Chief
Counsel
for
Advocacy
of
the
Small
Business
Administration.
Based
on
EPA's
experience
with
proposing
and
finalizing
SNURs,
State,
local,
and
tribal
governments
have
not
been
impacted
by
these
rulemakings,
and
EPA
does
not
have
any
reasons
to
believe
that
any
State,
local,
or
tribal
government
will
be
impacted
by
this
rulemaking.
As
such,
EPA
has
determined
that
this
regulatory
action
does
not
impose
any
enforceable
duty,
contain
any
unfunded
mandate,
or
otherwise
have
any
affect
on
small
governments
subject
to
the
requirements
of
sections
202,
203,
204,
or
205
of
the
Unfunded
Mandates
Reform
Act
of
1995
(
UMRA)
(
Public
Law
104
 
4).
This
action
will
not
have
a
substantial
direct
effect
on
States,
on
the
relationship
between
the
national
government
and
the
States,
or
on
the
distribution
of
power
and
responsibilities
among
the
various
levels
of
government,
as
specified
in
Executive
Order
13132,
entitled
Federalism
(
64
FR
43255,
August
10,
1999).
This
rule
does
not
have
tribal
implications
because
it
is
not
expected
to
have
substantial
direct
effects
on
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00034
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15079
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
Indian
Tribes.
This
does
not
significantly
or
uniquely
affect
the
communities
of
Indian
tribal
governments,
nor
does
it
involve
or
impose
any
requirements
that
affect
Indian
Tribes.
Accordingly,
the
requirements
of
Executive
Order
13175,
entitled
Consultation
and
Coordination
with
Indian
Tribal
Governments
(
65
FR
67249,
November
6,
2000),
do
not
apply
to
this
rule.
This
action
is
not
subject
to
Executive
Order
13045,
entitled
Protection
of
Children
from
Environmental
Health
Risks
and
Safety
Risks
(
62
FR
19885,
April
23,
1997),
because
this
is
not
an
economically
significant
regulatory
action
as
defined
by
Executive
Order
12866,
and
this
action
does
not
address
environmental
health
or
safety
risks
disproportionately
affecting
children.
This
rule
is
not
subject
to
Executive
Order
13211,
entitled
Actions
Concerning
Regulations
That
Significantly
Affect
Energy
Supply,
Distribution,
or
Use
(
66
FR
28355,
May
22,
2001),
because
this
action
is
not
expected
to
affect
energy
supply,
distribution,
or
use.
In
addition,
since
this
action
does
not
involve
any
technical
standards,
section
12(
d)
of
the
National
Technology
Transfer
and
Advancement
Act
of
1995
(
NTTAA),
Public
Law
104
 
113,
section
12(
d)
(
15
U.
S.
C.
272
note),
does
not
apply
to
this
action.
This
action
does
not
entail
special
considerations
of
environmental
justice
related
issues
as
delineated
by
Executive
Order
12898,
entitled
Federal
Actions
to
Address
Environmental
Justice
in
Minority
Populations
and
Low­
Income
Populations
(
59
FR
7629,
February
16,
1994).
EPA
has
complied
with
Executive
Order
12630,
entitled
Governmental
Actions
and
Interference
with
Constitutionally
Protected
Property
Rights
(
53
FR
8859,
March
15,
1988),
by
examining
the
takings
implications
of
this
rule
in
accordance
with
the
``
Attorney
General's
Supplemental
Guidelines
for
the
Evaluation
of
Risk
and
Avoidance
of
Unanticipated
Takings''
issued
under
the
Executive
Order.
In
issuing
this
rule,
EPA
has
taken
the
necessary
steps
to
eliminate
drafting
errors
and
ambiguity,
minimize
potential
litigation,
and
provide
a
clear
legal
standard
for
affected
conduct,
as
required
by
section
3
of
Executive
Order
12988,
entitled
Civil
Justice
Reform
(
61
FR
4729,
February
7,
1996).

XI.
Congressional
Review
Act
The
Congressional
Review
Act,
5
U.
S.
C.
801
et
seq.,
as
added
by
the
Small
Business
Regulatory
Enforcement
Fairness
Act
of
1996,
generally
provides
that
before
a
final
rule
may
take
effect,
the
Agency
promulgating
it
must
submit
a
final
rule
report,
which
includes
a
copy
of
the
final
rule,
to
each
House
of
the
Congress
and
to
the
Comptroller
General
of
the
United
States.
EPA
will
submit
a
report
containing
this
final
rule
and
other
required
information
to
the
U.
S.
Senate,
the
U.
S.
House
of
Representatives,
and
the
Comptroller
General
of
the
United
States
prior
to
publication
of
the
final
rule
in
the
Federal
Register.
This
final
rule
is
not
a
``
major
rule''
as
defined
by
5
U.
S.
C.
804(
2).

List
of
Subjects
in
40
CFR
Part
721
Environmental
protection,
Chemicals,
Hazardous
substances,
Reporting
and
recordkeeping
requirements.

Dated:
March
17,
2003.
Charles
M.
Auer,
Director,
Office
of
Pollution
Prevention
and
Toxics.


Therefore,
40
CFR
part
721
is
amended
as
follows:

PART
721
 
[
AMENDED]


1.
The
authority
citation
for
part
721
continues
to
read
as
follows:

Authority:
15
U.
S.
C.
2604,
2607,
and
2625(
c).


2.
By
adding
new
§
721.321
to
subpart
E
to
read
as
follows:

§
721.321
Substituted
acrylamides
and
acrylic
acid
copolymer
(
generic).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
substituted
acrylamides
and
acrylic
acid
copolymer
(
PMN
P
 
00
 
0490)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80
(
f),
(
v)(
1),
and
(
x)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


3.
By
adding
new
§
721.338
to
subpart
E
to
read
as
follows:
§
721.338
Salt
of
an
acrylate
copolymer
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substances
identified
generically
as
salt
of
an
acrylate
copolymer
(
PMNs
P
 
00
 
0333
and
P
 
00
 
0334)
are
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80
(
v)(
2),
(
w)(
2),
and
(
x)(
2).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


4.
By
adding
new
§
721.463
to
subpart
E
to
read
as
follows:

§
721.463
Acrylate
of
polymer
based
on
isophorone
diisocyanate
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
acrylate
of
polymer
based
on
isophorone
diisocyanate
(
PMN
P
 
00
 
0626)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
4),
(
b)(
4),
(
c)(
4)
(
N=
3
ppb).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


5.
By
adding
new
§
721.465
to
subpart
E
to
read
as
follows:

§
721.465
Alkoxylated
alkylpolyol
acrylates,
adduct
with
alkylamine
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00035
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15080
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
(
1)
The
chemical
substances
identified
generically
as
alkoxylated
alkylpolyol
acrylates,
adduct
with
alkylamine
(
PMNs
P
 
98
 
0082,
P
 
98
 
0083,
and
P
 
98
 
0084
are
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


6.
By
adding
new
§
721.522
to
subpart
E
to
read
as
follows:

§
721.522
Oxirane,
methyl­,
polymer
with
oxirane,
mono(
3,5,5,­
trimethylhexyl)
ether.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
oxirane,
methyl­,
polymer
with
oxirane,
mono(
3,5,5,­
trimethylhexyl)
ether
(
PMN
P
 
99
 
0669;
CAS
No.
204336
 
40
 
3)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
j).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.
(
3)
Determining
whether
a
specific
use
is
subject
to
this
section.
The
provisions
of
§
721.1725(
b)(
1)
apply
to
this
section.


7.
By
adding
new
§
721.525
to
subpart
E
to
read
as
follows:

§
721.525
1­
propanol,
3­
propoxy­.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
1­
propanol,
3­
propoxy­
(
PMN
P
 
00
 
0827;
CAS
No.
4161
 
22
 
2)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Protection
in
the
workplace.
Requirements
as
specified
in
§
721.63
(
a)(
2)(
i)
and
(
a)(
3).
(
ii)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
o)
and
(
j).
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
(
d),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.
(
3)
Determining
whether
a
specific
use
is
subject
to
this
section.
The
provisions
of
§
721.1725(
b)(
1)
apply
to
this
section.


8.
By
adding
new
§
721.532
to
subpart
E
to
read
as
follows:

§
721.532
Substituted
hydroxyalkane
acetate
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
substituted
hydroxyalkane
acetate
(
PMN
P
 
00
 
0618)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80
(
j).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.
(
3)
Determining
whether
a
specific
use
is
subject
to
this
section.
The
provisions
of
§
721.1725(
b)(
1)
apply
to
this
section.


9.
By
adding
new
§
721.533
to
subpart
E
to
read
as
follows:

§
721.533
Propane,
1,1,1,3,3­
pentachloro­.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
propane,
1,1,1,3,3­
pentachloro­
(
PMN
P
 
99
 
1327;
CAS
No.
23153
 
23
 
3)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
g).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


10.
By
adding
new
§
721.638
to
subpart
E
to
read
as
follows:

§
721.638
Silyl
amine,
potassium
salt
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
silyl
amine,
potassium
salt
(
PMN
P
 
00
 
1086)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitation
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


11.
By
adding
new
§
721.648
to
subpart
E
to
read
as
follows:

§
721.648
Alkyl
dialkylamino
phenylsulfonyl
alkenoate
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
alkyl
dialkylamino
phenylsulfonyl
alkenoate
(
PMN
P
 
00
 
0816)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00036
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15081
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
f).
(
ii)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
(
i),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


12.
By
adding
new
§
721.843
to
subpart
E
to
read
as
follows:

§
721.843
Substituted
phenylazophenylazo
phenol
(
generic).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
substituted
phenylazophenylazo,
phenol
(
PMN
P
 
00
 
0420)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


13.
By
adding
new
§
721.910
to
subpart
E
to
read
as
follows:

§
721.910
Propanetriol
polyalkylenepolyolamine
aryl
aldimine
(
generic).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
propanetriol
polyalkylenepolyolamine
aryl
aldimine
(
PMN
P
 
99
 
0873)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


14.
By
adding
new
§
721.984
to
subpart
E
to
read
as
follows:

§
721.984
Amino­
hydroxy
sulfonaphthylazo­
disubstituted
phenyl
azo
benzene
carboxylate
salt
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
amino­
hydroxy
sulfonaphthylazo­
disubstituted
phenyl
azo
benzene
carboxylate
salt
(
PMN
P
 
00
 
0351)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80
(
v)(
2),
(
w)(
2),
(
x)(
2).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


15.
By
adding
new
§
721.990
to
subpart
E
to
read
as
follows:

§
721.990
1,4­
Benzedicarboxylic
acid,
dimethyl
ester,
polymer
with
1,4
­
butanediol,
cyclized.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
1,4­
benzedicarboxylic
acid,
dimethyl
ester,
polymer
with
1,4
­
butanediol,
cyclized
(
PMN
P
 
00
 
0789;
CAS
No.
263244
 
54
 
8)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


16.
By
adding
new
§
721.1767
to
subpart
E
to
read
as
follows:

§
721.1767
Substituted
6,6'­(
1­
methylethylidene)
bis[
3,4­
dihydro­
3­
phenyl­
1,3­
benzoxazine]
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
substituted
6,6'­(
1­
methylethylidene)
bis[
3,4­
dihydro­
3­
phenyl­
1,3­
benzoxazine]
(
PMN
P
 
00
 
0993)
is
subject
to
reporting
under
this
section
for
the
significant
new
uses
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


17.
By
adding
new
§
721.1852
to
subpart
E
to
read
as
follows:

§
721.1852
Di­
alkyl
borane
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
di­
alkyl
borane
(
PMN
P
 
00
 
1087)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
4),
(
b)(
4),
and
(
c)(
4)
(
N=
200
ppb).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00037
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15082
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
(
i)
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


18.
By
adding
new
§
721.1878
to
subpart
E
to
read
as
follows:

§
721.1878
Alkali
metal
alkyl
borohydride
(
generic).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
alkali
metal
alkyl
borohydride
(
PMN
P
 
00
 
1089)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


19.
By
adding
new
§
721.1880
to
subpart
E
to
read
as
follows:

§
721.1880
Borate(
1­),
tris(
acetato­
.
kappa.
O)
hydro­,
sodium,
(
T­
4)­.
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
borate(
1­),
tris(
acetato­.
kappa.
O)
hydro­,
sodium,
(
T­
4)­
(
PMN
P
 
00
 
0922;
CAS
No.
56553
 
60
 
7)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
4),
(
b)(
4),
and
(
c)(
4)
(
N=
300
ppb).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


20.
By
adding
new
§
721.2093
to
subpart
E
to
read
as
follows:

§
721.2093
Alkenyl
carboxylate,
metal
salt
(
generic).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
alkenyl
carboxylate,
metal
salt
(
PMN
P
 
99
 
0848)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
j)
(
an
emulsifier
for
metalworking
fluids)
and
(
q).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.
(
3)
Determining
whether
a
specific
use
is
subject
to
this
section.
The
provisions
of
§
721.1725(
b)(
1)
apply
to
this
section.


21.
By
adding
new
§
721.2155
to
subpart
E
to
read
as
follows:

§
721.2155
Alkoxyamino­
alkyl­
coumarin
(
generic).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
alkoxyamino­
alkylcoumarin
(
PMN
P
 
00
 
0108)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
f).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


22.
By
adding
new
§
721.2465
to
subpart
E
to
read
as
follows:
§
721.2465
Xanthylium,
9­(
2­
(
ethoxycarbonyl)
phenyl)­
3,6­
bis(
ethylamino)­
2,7­
dimethyl­,
ethyl
sulfate.
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
xanthylium,
9­(
2­
(
ethoxycarbonyl)
phenyl)­
3,6­
bis(
ethylamino)­
2,7­
dimethyl­,
ethyl
sulfate
(
PMN
P
 
00
 
1195;
CAS
No.
26694
 
69
 
9)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
f)
and
(
j)
(
a
basic
dye
for
complex
basic
dye
pigment
manufacture).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


23.
By
adding
new
§
721.2577
to
subpart
E
to
read
as
follows:

§
721.2577
Copper
complex
of
(
substituted
sulfonaphthyl
azo
substituted
phenyl)
disulfonaphthyl
azo,
amine
salt
(
generic).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substances
identified
generically
as
copper
complex
of
(
substituted
sulfonaphthyl
azo
substituted
phenyl)
disulfonaphthyl
azo,
amine
salt
(
PMNs
P
 
00
 
0364
and
P
 
00
 
0365)
are
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80
(
v)(
1),
(
w)(
1),
(
x)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00038
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15083
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations

24.
By
adding
new
§
721.2582
to
subpart
E
to
read
as
follows:

§
721.2582
Reaction
product
of
alkylene
diamine,
MDl,
substituted
carbomonocyclic
amine
and
alkylamine
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
reaction
product
of
alkylene
diamine,
MDl,
substituted
carbomonocyclic
amine
and
alkylamine
(
PMN
P
 
98
 
1262)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


25.
By
adding
new
§
721.2584
to
subpart
E
to
read
as
follows:

§
721.2584
Dodecanoic
acid,
12­
amino­.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
dodecanoic
acid,
12­
amino­
(
PMN
P
 
98
 
0823;
CAS
No.
693
 
57
 
2)
is
subject
to
reporting
under
this
section
for
the
significant
new
uses
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Protection
in
the
workplace.
Requirements
as
specified
in
§
721.63
(
a)(
4),
(
a)(
5)(
iii),
(
a)(
5)(
iv),
(
a)(
5)(
v),
(
a)(
5)(
vi),
(
a)(
5)(
vii),
(
a)(
6)(
i),
(
b)
(
concentration
set
at
0.1
percent),
and
(
g).
As
an
alternative
to
the
respiratory
requirements
listed
here,
a
manufacturer,
importer,
or
processor
may
choose
to
follow
the
NCEL
provision
listed
in
the
5(
e)
consent
order
for
this
substance.
The
NCEL
is
1.0
mg/
m3
as
an
8­
hour
time­
weighted
average
verified
by
actual
monitoring
data.
(
ii)
Hazard
communication
program.
Requirements
as
specified
in
§
721.72
(
a),
(
b),
(
c),
(
d),
(
e),
(
f),
(
g)(
1)(
ii),
(
g)(
1)(
vii),
(
g)(
2)(
ii),
and
(
g)(
2)(
iv).
(
iii)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80
(
g),
(
r)
(
6,000,000
kg.),
and
a
carcinogenicity
study
(
OPPTS
870.4200).
A
person
may
not
manufacture
or
import
the
substance
beyond
the
aggregate
production
volume
limit,
unless
that
person
conducts
this
study
on
the
substance
and
submits
all
final
reports
and
underlying
data
in
accordance
with
the
procedures
and
criteria
specified
in
paragraphs
(
a)(
2)(
iii)(
A),
(
a)(
2)(
iii)(
B),
(
a)(
2)(
iii)(
C),
and
(
a)(
2)(
iii)(
D)
of
this
section.
(
A)
Each
study
required
to
be
performed
pursuant
to
this
section
must
be
scientifically
valid.
Scientifically
valid
means
that
the
study
was
conducted
according
to:
(
1)
The
test
guidelines
specified
in
paragraph
(
a)(
2)(
iii)
of
this
section.
(
2)
An
EPA­
approved
protocol.
(
3)
TSCA
Good
Laboratory
Practice
Standards
at
40
CFR
part
792.
(
4)
Using
methodologies
generally
accepted
at
the
time
the
study
is
initiated.
(
5)
Any
deviation
from
these
requirements
must
be
approved
in
writing
by
EPA.
(
B)
Before
starting
to
conduct
any
of
the
studies
in
paragraph
(
a)(
2)(
iii)
of
this
section,
the
person
must
obtain
approval
of
test
protocols
from
EPA
by
submitting
written
protocols.
EPA
will
respond
to
the
person
within
4
weeks
of
receiving
the
written
protocols.
Published
test
guidelines
specified
in
paragraph
(
a)(
2)(
iii)
of
this
section
(
e.
g.,
40
CFR
part
797
or
part
798)
provide
general
guidance
for
development
of
test
protocols,
but
are
not
themselves
acceptable
protocols.
(
C)
The
person
shall:
(
1)
Conduct
each
study
in
good
faith
with
due
care.
(
2)
Promptly
furnish
to
EPA
the
results
of
any
interim
phase
of
each
study.
(
3)
Submit,
in
triplicate
(
with
an
additional
sanitized
copy,
if
confidential
business
information
is
involved),
the
final
report
of
each
study
and
all
underlying
data
(``
the
report
and
data'')
to
EPA
no
later
than
14
weeks
prior
to
exceeding
the
applicable
production
volume
limit.
The
final
report
shall
contain
the
contents
specified
in
40
CFR
792.185.
(
D)(
1)
Except
as
described
in
paragraph
(
a)(
2)(
iii)(
D)(
2)
of
this
section,
if,
within
6
weeks
of
EPA's
receipt
of
a
test
report
and
data,
the
person
receives
written
notice
that
EPA
finds
that
the
data
generated
by
a
study
are
scientifically
invalid,
the
person
is
prohibited
from
further
manufacture
and
import
of
the
PMN
substance
beyond
the
applicable
production
volume
limit.
(
2)
The
person
may
continue
to
manufacture
and
import
the
PMN
substance
beyond
the
applicable
production
limit
only
if
so
notified,
in
writing,
by
EPA
in
response
to
the
person's
compliance
with
either
of
the
following
paragraphs
(
a)(
2)(
iii)(
D)(
2)(
i)
or
(
a)(
2)(
iii)(
D)(
2)(
ii)
of
this
section.
(
i)
The
person
may
reconduct
the
study.
If
there
is
sufficient
time
to
reconduct
the
study
and
submit
the
report
and
data
to
EPA
at
least
14
weeks
before
exceeding
the
production
limit
as
required
by
paragraph
(
a)(
2)(
iii)(
C)(
3)
of
this
section,
the
person
shall
comply
with
paragraph
(
a)(
2)(
iii)(
C)(
3)
of
this
section.
If
there
is
insufficient
time
for
the
person
to
comply
with
paragraph
(
a)(
2)(
iii)(
C)(
3)
of
this
section,
the
person
may
exceed
the
production
limit
and
shall
submit
the
report
and
data
in
triplicate
to
EPA
within
a
reasonable
period
of
time,
all
as
specified
by
EPA
in
the
notice
described
in
paragraph
(
a)(
2)(
iii)(
D)(
1)
of
this
section.
EPA
will
respond
to
the
person
in
writing,
within
6
weeks
of
receiving
the
person's
report
and
data.
(
ii)
The
person
may,
within
4
weeks
of
receiving
from
EPA
the
notice
described
in
paragraph
(
a)(
2)(
iii)(
D)(
1)
of
this
section,
submit
to
EPA
a
written
report
refuting
EPA's
finding.
EPA
will
respond
to
the
person
in
writing,
within
4
weeks
of
receiving
the
person's
report.
(
E)
The
person
is
not
required
to
conduct
a
study
specified
in
paragraph
(
a)(
2)(
iii)
of
this
section
if
notified
in
writing
by
EPA
that
it
is
unnecessary
to
conduct
that
study.
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
(
d),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


26.
By
adding
new
§
721.2673
to
subpart
E
to
read
as
follows:

§
721.2673
Aromatic
epoxide
resin
(
generic).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
aromatic
epoxide
resin
(
PMN
P
 
99
 
1399)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
y)(
1).
(
ii)
[
Reserved]

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00039
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15084
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


27.
By
adding
new
§
721.3805
to
subpart
E
to
read
as
follows:

§
721.3805
Formaldehyde,
reaction
products
with
1,3­
benzenedimethanamine
and
bisphenol
A.
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
formaldehyde,
reaction
products
with
1,3­
benzenedimethanamine
and
bisphenol
A
(
PMN
P
 
00
 
0738;
CAS
No.
259871
 
68
 
6)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


28.
By
adding
new
§
721.3807
to
subpart
E
to
read
as
follows:

§
721.3807
Formaldehyde,
polymer
with
phenol
and
1,2,3­
propanetriol,
methylated.
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
formaldehyde,
polymer
with
phenol
and
1,2,3­
propanetriol,
methylated
(
PMN
P
 
99
 
0044;
CAS
No.
209810
 
57
 
1)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
4),
(
b)(
4),
and
(
c)(
4)
(
N=
3
ppb).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


29.
By
adding
new
§
721.3812
to
subpart
E
to
read
as
follows:

§
721.3812
Substituted
phenols
and
formaldehyde
polymer,
alkylated
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
substituted
phenols
and
formaldehyde
polymer,
alkylated
(
PMN
P
 
00
 
0542)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
j)
(
a
resin
for
can
and
tube
coatings).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


30.
By
adding
new
§
721.3818
to
subpart
E
to
read
as
follows:

§
721.3818
Furan,
octafluorotetrahydro­.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
furan,
octafluorotetrahydro­
(
PMN
P
 
99
 
0965;
CAS
No.
773
 
14
 
8)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
j)
(
a
heat
transfer
agent).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


31.
By
adding
new
§
721.3848
to
subpart
E
to
read
as
follows:

§
721.3848
Glycine,
N­(
carboxymethyl)­
Ndodecyl
monosodium
salt.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
glycine,
N­(
carboxymethyl)­
N­
dodecyl­,
monosodium
salt
(
PMN
P
 
00
 
469;
CAS
No.
141321
 
68
 
8)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
4),
(
b)(
4),
(
c)(
4)
(
N=
30
ppb).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


32.
By
adding
new
§
721.4136
to
subpart
E
to
read
as
follows:

§
721.4136
Alkyl
heteropolycyclic­
aniline
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
alkyl
heteropolycyclicaniline
(
PMN
P
 
00
 
0067)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
4),
(
b)(
4),
and
(
c)(
4)
(
N=
1
ppb).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


33.
By
adding
new
§
721.4486
to
subpart
E
to
read
as
follows:

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00040
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15085
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
§
721.4486
Propanoic
acid,
2­
methyl­,
(
1R,
2R,
4R)­
1,7,7­
trimethylbicyclo[
2.2.1]
hept­
2­
yl
ester,
rel­.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substances
identified
as
propanoic
acid,
2­
methyl­,
(
1R,
2R,
4R)­
1,7,7­
trimethylbicyclo[
2.2.1]
hept­
2­
yl
ester,
rel­
(
PMNs
P
 
98
 
0497
and
P
 
98
 
0509;
CAS
No.
85586
 
67
 
0)
are
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
p)
(
15,000
kg/
yr).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


34.
By
adding
new
§
721.4575
to
subpart
E
to
read
as
follows:

§
721.4575
L­
aspartic
acid,
N,
N'­
[(
1E)
­
1,2
­
ethenediylbis[(
3­
sulfo­
4,
1­
phenylene)
imino
[
6­(
phenylamino)­
1,3,5­
triazine­
4,2­
diyl]]]
bis­,
hexasodium
salt.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
l­
aspartic
acid,
N,
N'­
[(
1E)
­
1,2
­
ethenediylbis[(
3­
sulfo­
4,
1­
phenylene)
imino[
6­(
phenylamino)­
1,3,5­
triazine­
4,2­
diyl]]]
bis­,
hexasodium
salt
(
PMN
P
 
99
 
1167;
CAS
No.
205764
 
98
 
3)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80
(
v)(
1),
(
w)(
1),
(
x)(
1),
and
(
f).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.

35.
By
adding
new
§
721.4792
to
subpart
E
to
read
as
follows:

§
721.4792
2­
propenoic
acid,
2­
methyl­,
C11­
14­
isoalkyl
esters,
C13­
rich.
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
2­
propenoic
acid,
2­
methyl­,
C11­
14­
isoalkyl
esters,
C13­
rich
(
PMN
P
 
99
 
1189;
CAS
No.
85736
 
97
 
6)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
j)
(
a
monomer
for
casting
automotive
parts
adhesives
or
impregnation
fluid).
(
ii)
Release
to
water.
Requirements
as
specified
in
§
721.90(
c)(
4)
(
N=
1
ppb).
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
(
i),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


36.
By
adding
new
§
721.5260
to
subpart
E
to
read
as
follows:

§
721.5260
1,3,6­
Naphthalenetrisulfonic
acid,
7­[[
2­[(
aminocarbonyl)
amino]­
4­[[
4­[[
2­
[
2­(
ethenylsulfonyl)
ethoxy]
ethyl]
amino]­
6­
fluoro­
1,3,5­
triazin­
2­
yl]
amino]
phenyl]
azo],
trisodium
salt.
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
1,3,6­
Naphthalenetrisulfonic
acid,
7­[[
2­
[(
aminocarbonyl)
amino]­
4­[[
4­[[
2­[
2­
(
ethenylsulfonyl)
ethoxy]
ethyl]
amino]­
6­
fluoro­
1,3,5­
triazin­
2­
yl]
amino]
phenyl]
azo],
trisodium
salt
(
PMN
P
 
00
 
0806;
CAS
No.
106359
 
91
 
5)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
f).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


37.
By
adding
new
§
721.5262
to
subpart
E
to
read
as
follows:

§
721.5262
2,7­
Naphthalenedisulfonic
acid,
5­[[
4­
chloro­
6­[
substituted]
amino]­
1,3,5­
triazin­
2­
yl]
amino]­
4­
hydroxy­
3­[(
1­
sulfo­
2­
naphthalenyl)
azo]­,
trisodium
salt
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
2,7­
Naphthalenedisulfonic
acid,
5­[[
4­
chloro­
6­[
substituted]
amino]­
1,3,5­
triazin­
2­
yl]
amino]­
4­
hydroxy­
3­[(
1­
sulfo­
2­
naphthalenyl)
azo]­,
trisodium
salt
(
PMN
P
 
00
 
0803)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
f).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


38.
By
adding
new
§
721.5283
to
subpart
E
to
read
as
follows:

§
721.5283
Cobaltate
(
5­),
bis[
4­[[
6­[(
4­
amino­
6­
chloro­
1,3,5­
triazin­
2­
yl)
amio]­
1­
hydroxy­
3­
sulfo­
2­
naphthalenyl]
azo]­
3­
hydroxy­
7­
nitro­
1­
naphthalenesulfonato(
4­
)]­,
pentasodium.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
cobaltate
(
5­),
bis[
4­[[
6­[(
4­
amino­
6­
chloro­
1,3,5­
triazin­
2­
yl)
amio]­
1­
hydroxy­
3­
sulfo­
2­
naphthalenyl]
azo]­
3­
hydroxy­
7­
nitro­
1­
naphthalenesulfonato(
4­)]­,
pentasodium
(
PMN
P
 
99
 
0990;
CAS
No.
91144
 
26
 
2)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Protection
in
the
workplace.
Requirements
as
specified
in
§
721.63
(
a)(
4),
(
a)(
5)(
ii),
(
a)(
5)(
xii),
and
(
a)(
5)(
xiii).
(
ii)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00041
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15086
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
specified
in
§
721.80(
j)
(
a
spray
applied
automotive
coating).
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
(
d),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


39.
By
adding
new
§
721.5286
to
subpart
E
to
read
as
follows:

§
721.5286
Benzenediazonium,
[[[[(
substituted)
azo]
phenyl]
sulfonyl]
amino]­,
coupled
with
aminophenol,
diazotized
aminobenzoic
acid,
diazotized
(
substituted)
benzenesulfonic
acid
and
naphthalenol
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
benzenediazonium,
[[[[(
substituted)
azo]
phenyl]
sulfonyl]
amino]­,
coupled
with
aminophenol,
diazotized
aminobenzoic
acid,
diazotized
(
substituted)
benzenesulfonic
acid
and
naphthalenol
(
PMN
P
 
00
 
0045)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
f).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


40.
By
adding
new
§
721.5452
to
subpart
E
to
read
as
follows:

§
721.5452
Alkali
metal
salt
of
halogenated
organoborate
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substances
identified
generically
as
alkali
metal
salt
of
halogenated
organoborate
(
PMN
P
 
00
 
0638)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


41.
By
adding
new
§
721.5454
to
subpart
E
to
read
as
follows:

§
721.5454
Methylium,
tripohenyl­,
tetrakis(
pentafluorophenyl)
borate
(
1­).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substances
identified
as
methylium,
tripohenyl­,
tetrakis(
pentafluorophenyl)
borate
(
1­)
(
PMN
P
 
00
 
0637;
CAS
No.
136040
 
19
 
2)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


42.
By
adding
new
§
721.5590
to
subpart
E
to
read
as
follows:

§
721.5590
Oxirane,
[[[(
1R,
2S,
5R)­
5­
methyl­
2­(
1­
methylethyl)
cyclohexyl]
oxy]
methyl]­.
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
oxirane,
[[[(
1R,
2S,
5R)­
5­
methyl­
2­(
1­
methylethyl)
cyclohexyl]
oxy]
methyl]­
(
PMN
P
 
00
 
0330;
CAS
No.
249297
 
16
 
3)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
g).
(
ii)
Release
to
water.
Requirements
as
specified
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
(
i),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


43.
By
adding
new
§
721.5925
to
subpart
E
to
read
as
follows:

§
721.5925
Bis
heterocyclic
phenylene
derivative
(
generic).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
bis
heterocyclic
phenylene
derivative
(
PMN
P
 
01
 
0432)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
p)
(
20,000
kg/
yr).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


44.
By
adding
new
§
721.6005
to
subpart
E
to
read
as
follows:

§
721.6005
Rare
earth
phosphate
(
generic).
(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substances
identified
generically
as
rare
earth
phophate
(
PMNs
P
 
99
 
1191
and
P
 
99
 
1192)
are
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
4),
(
b)(
4),
and
(
c)(
4)
(
N=
10).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00042
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15087
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


45.
By
adding
new
§
721.6178
to
subpart
E
to
read
as
follows:

§
721.6178
Alkylaminated
polyolefin
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
alkylaminated
polyolefin
(
PMN
P
 
99
 
1287)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


46.
By
adding
new
§
721.6181
to
subpart
E
to
read
as
follows:

§
721.6181
Fatty
acid,
reaction
product
with
substituted
oxirane,
formaldehydephenol
polymer
glycidyl
ether,
substituted
proplyamine
and
polyethylenepolyamines
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
fatty
acid,
reaction
product
with
substituted
oxirane,
formaldehyde­
phenol
polymer
glycidyl
ether,
substituted
proplyamine
and
polyethylenepolyamines
(
PMN
P
 
98
 
1125)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
4),
(
b)(
4),
and
(
c)(
4)
(
N=
10ppb).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


47.
By
adding
new
§
721.6183
to
subpart
E
to
read
as
follows:

§
721.6183
Amides,
from
ammonium
hydroxide
­
maleic
anhydride
polymer
and
hydrogenated
tallow
alkyl
amines,
sodium
salts,
compds.
with
ethanolamine.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
amides,
from
ammonium
hydroxide
­
maleic
anhydride
polymer
and
hydrogenated
tallow
alkyl
amines,
sodium
salts,
compds.
with
ethanolamine
(
PMN
P
 
00
 
0691;
CAS
No.
208408
 
03
 
1)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
4),
(
b)(
4),
and
(
c)(
4)
(
N=
80
ppb).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


48.
By
adding
new
§
721.6205
to
subpart
E
to
read
as
follows:

§
721.6205
Hexamethylenediamine
adduct
of
substituted
piperidinyloxy
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
hexamethylenediamine
adduct
of
substituted
piperidinyloxy
(
PMN
P
 
99
 
0510)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Protection
in
the
workplace.
Requirements
as
specified
in
§
721.63
(
a)(
i),
(
a)(
2)(
i),
(
a)(
3),
(
a)(
4),
(
a)(
5)(
i),
(
a)(
5)(
ii),
(
a)(
5)(
iii),
(
a)(
5)(
iv),
(
a)(
5)(
v),
(
a)(
5)(
vi),
(
a)(
5)(
vii),
(
a)(
5)(
viii),
(
a)(
5)(
ix),
(
a)(
5)(
x),
(
a)(
5)(
xi),
(
a)(
5)(
xii),
(
a)(
5)(
xiii)
(
a)(
5)(
xiv),
(
a)(
5)(
xv),
(
a)(
6)(
i),
(
a)(
6)(
ii),
(
a)(
6)(
iii),
(
a)(
6)(
iv),
(
a)(
6)(
v),
and
(
a)(
6)(
vi),
(
b)
(
concentration
set
at
1.0
percent),
and
(
c).
The
imperviousness
of
each
item
pursuant
to
paragraph
(
a)(
2)(
i)
must
be
demonstrated
by
actual
testing
under
paragraph
(
a)(
3)
and
not
by
manufacturer
specifications.
Permeation
testing
shall
be
conducted
according
to
the
American
Society
for
Testing
and
Materials
(
ASTM)
F739
``
Standard
Test
Method
for
Resistance
of
Protective
Clothing
Materials
to
Permeation
by
Liquids
or
Gases''
or
its
equivalent.
Results
shall
be
recorded
as
a
cumulative
permeation
rate
as
a
function
of
time,
and
shall
be
documented
in
accordance
with
ASTM
F739
using
the
format
specified
in
ASTM
1194
 
89
``
Guide
for
Documenting
the
Results
of
Chemical
Permeation
Testing
on
Protective
Clothing
Materials''
or
its
equivalent.
Gloves
may
not
be
used
for
a
time
period
longer
than
they
are
actually
tested
and
must
be
replaced
at
the
end
of
each
work
shift.
The
manufacturer,
importer,
or
processor
must
submit
all
test
data
to
the
Agency
and
must
receive
written
Agency
approval
for
each
type
of
glove
tested
prior
to
use
of
such
gloves.
The
following
gloves
have
been
tested
in
accordance
with
the
ASTM
F739
method
and
found
to
satisfy
the
requirements
for
use
by
EPA:
Latex
(
at
least
14
mils
thick),
Nitrile
(
at
least
16
mils
thick),
and
Silvershield
(
at
least
3
mils
thick).
As
an
alternative
to
the
respiratory
requirements
listed
here,
a
manufacturer,
importer,
or
processor
may
choose
to
follow
the
NCEL
provisions
listed
in
the
TSCA
section
5(
e)
consent
order
for
this
substance.
The
NCEL
is
0.2
ug/
m3
as
an
8­
hour
time
weighted
average
verified
by
actual
monitoring
data.
(
ii)
Hazard
communication
program.
Requirements
as
specified
in
§
721.72
(
a),
(
b),
(
c),
(
d),
(
e)
(
concentration
set
at
0.1
percent),
(
f),
(
g)(
1)(
i),
(
g)(
1)(
ii),
(
g)(
1)(
iv),
(
g)(
1)(
vi),
(
g)(
1)(
viii),
(
g)(
2)(
i),
(
g)(
2)(
ii),
(
g)(
2)(
iv),
(
g)(
2)(
v),
and
(
g)(
5).
(
iii)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
q).
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
(
d),
(
e),
(
f),
(
g),
(
h),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.
(
3)
Determining
whether
a
specific
use
is
subject
to
this
section.
The
provisions
of
§
721.1725(
b)(
1)
apply
to
this
section.

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00043
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15088
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations

49.
By
adding
new
§
721.8085
to
subpart
E
to
read
as
follows:

§
721.8085
Reaction
product
of
substituted
aromatic
diol,
formaldehyde
and
alkanolamine,
propoxylated
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
reaction
product
of
substituted
aromatic
diol,
formaldehyde
and
alkanolamine,
propoxylated
(
PMN
P
 
00
 
0202)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


50.
By
adding
new
§
721.8658
to
subpart
E
to
read
as
follows:

§
721.8658
Modified
polymer
of
vinyl
acetate
and
quaternary
ammonium
compound
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
modified
polymer
of
vinyl
acetate
and
quaternary
ammonium
compound
(
PMN
P
 
99
 
0874)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
f).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


51.
By
adding
new
§
721.8920
to
subpart
E
to
read
as
follows:
§
721.8920
4,6­
Disubstituted
pyrimidine
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
4,6­
disubstituted
pyrimidine
(
PMN
P
 
99
 
1366)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
f).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


52.
By
adding
new
§
721.9502
to
subpart
E
to
read
as
follows:

§
721.9502
Siloxanes
and
silicones,
aminoalkyl,
fluorooctyl,
hydroxy­
terminated
salt
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
siloxanes
and
silicones,
aminoalkyl,
fluorooctyl,
hydroxyterminated
salt
(
PMN
P
 
00
 
1132)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
j)
(
graffiti
systems)
and
(
y)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.
(
3)
Determining
whether
a
specific
use
is
subject
to
this
section.
The
provisions
of
§
721.1725(
b)(
1)
apply
to
this
section.


53.
By
adding
new
§
721.9504
to
subpart
E
to
read
as
follows:
§
721.9504
Silane,
triethoxy
(
3,3,4,4,5,5,
6,6,7,7,8,8,8­
tridecafluorooctyl)­.

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
as
silane,
triethoxy
(
3,3,4,4,5,
5,6,6,7,7,8,8,8­
tridecafluorooctyl)­
(
PMN
P
 
99
 
1346;
CAS
No.
51851
 
37
 
7)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Protection
in
the
workplace.
Requirements
as
specified
in
§
721.63
(
a)(
4),
(
a)(
5)(
ii),(
(
a)(
5)(
xii),
and
(
a)(
5)(
xiii).
(
ii)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
o).
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),(
b),
(
c),
(
d),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


54.
By
adding
new
§
721.9520
to
subpart
E
to
read
as
follows:

§
721.9520
Methylated­
para­
rosaniline
salt
of
a
trisulfonated
triarylmethane
dye
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
methylated­
pararosaniline
salt
of
a
trisulfonated
triarylmethane
dye
(
PMN
P
 
00
 
0559)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80(
f).
(
ii)
Release
to
water.
Requirements
as
specified
in
§
721.90
(
a)(
4),
(
b)(
4),
(
c)(
4)
(
N=
2
ppb).
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
(
i),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


55.
By
adding
new
§
721.9538
to
subpart
E
to
read
as
follows:

VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00044
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1
15089
Federal
Register
/
Vol.
68,
No.
60
/
Friday,
March
28,
2003
/
Rules
and
Regulations
§
721.9538
Lithium
salt
of
sulfophenyl
azo
phenyl
azo
disulfostilbene
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
lithium
salt
of
sulfophenyl
azo
phenyl
azo
disulfostilbene
(
PMN
P
 
00
 
0698)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80
(
v)(
2),
(
w)(
2),
(
x)(
2).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


56.
By
adding
new
§
721.9597
to
subpart
E
to
read
as
follows:

§
721.9597
Salt
of
a
substituted
sulfonated
aryl
azo
compound
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
salt
of
a
substituted
sulfonated
aryl
azo
compound
(
PMN
P
 
00
 
0094)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Industrial,
commercial,
and
consumer
activities.
Requirements
as
specified
in
§
721.80
(
f).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
i)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.


57.
By
adding
new
§
721.9952
to
subpart
E
to
read
as
follows:

§
721.9952
Alkoxylated
aliphatic
diisocyanate
allyl
ether
(
generic).

(
a)
Chemical
substance
and
significant
new
uses
subject
to
reporting.
(
1)
The
chemical
substance
identified
generically
as
alkoxylated
aliphatic
diisocyanate
allyl
ether
(
PMN
P
 
00
 
0353)
is
subject
to
reporting
under
this
section
for
the
significant
new
use
described
in
paragraph
(
a)(
2)
of
this
section.
(
2)
The
significant
new
uses
are:
(
i)
Release
to
water.
Requirements
as
specified
§
721.90
(
a)(
1),
(
b)(
1),
and
(
c)(
1).
(
ii)
[
Reserved]
(
b)
Specific
requirements.
The
provisions
of
subpart
A
of
this
part
apply
to
this
section
except
as
modified
by
this
paragraph.
(
1)
Recordkeeping.
Recordkeeping
requirements
as
specified
in
§
721.125
(
a),
(
b),
(
c),
and
(
k)
are
applicable
to
manufacturers,
importers,
and
processors
of
this
substance.
(
2)
Limitations
or
revocation
of
certain
notification
requirements.
The
provisions
of
§
721.185
apply
to
this
section.

[
FR
Doc.
03
 
7373
Filed
3
 
27
 
03;
8:
45
am]

BILLING
CODE
6560
 
50
 
S
GENERAL
SERVICES
ADMINISTRATION
41
CFR
Part
102
 
173
[
FMR
Amendment
2003
 
1]

RIN
3090
 
AH41
Federal
Management
Regulation;
Internet
GOV
Domain
AGENCY:
Office
of
Governmentwide
Policy,
GSA.
ACTION:
Final
rule.

SUMMARY:
The
General
Services
Administration
(
GSA)
is
adding
coverage
on
the
Internet
GOV
Domain
to
the
Federal
Management
Regulation
(
FMR).
The
purpose
of
this
final
rule
is
to
provide
a
new
policy
for
registration
of
domain
names.
The
FMR
is
written
in
plain
language
to
provide
updated
regulatory
material
that
is
easy
to
read
and
understand.
DATES:
Effective
Date:
March
28,
2003.

FOR
FURTHER
INFORMATION
CONTACT:
The
Regulatory
Secretariat,
Room
4035,
GS
Building,
Washington,
DC,
20405,
(
202)
208
 
7312,
for
information
pertaining
to
status
or
publication
schedules.
For
clarification
of
content,
contact
Lee
Ellis,
Office
of
Electronic
Government
and
Technology,
at
(
202)
501
 
0282,
lee.
ellis@
gsa.
gov.
Please
cite
FMR
Amendment
2003
 
1.

SUPPLEMENTARY
INFORMATION:
A.
Background
The
purpose
of
this
final
rule
is
to
provide
a
new
policy
for
the
Internet
GOV
Domain
that
will
be
included
in
the
FMR.
The
final
rule
is
written
in
a
plain
language
question
and
answer
format.
This
style
uses
an
active
voice,
shorter
sentences,
and
pronouns.
Unless
otherwise
indicated
in
the
text,
the
pronoun
``
we''
refers
to
the
General
Services
Administration
(
GSA).
A
question
and
its
answer
combine
to
establish
a
rule.
You
must
follow
the
language
contained
in
both
the
question
and
its
answer.
This
final
rule
establishes
FMR
part
102
 
173,
Internet
GOV
Domain,
and
provides
policy
for
registration
of
domain
names.
A
proposed
rule
was
published
in
the
Federal
Register
at
67
FR
34890,
May
16,
2002.
Public
comments
were
solicited
for
use
in
the
formulation
of
the
final
rule.
All
comments
were
consolidated
and
each
one
considered
through
a
formal
process.
Comments
received
were
from
private
citizens,
Federal,
State,
and
local
government
organizations,
information
technology
standards
organizations,
and
commercial
businesses.
Particularly
worth
noting
are
the
comments
concerning
the
cost
for
dot­
gov
registration.
GSA
currently
assesses
no
charge.
The
rule
merely
establishes
a
ceiling
for
the
charges
that
GSA
may
assess
in
the
future
if
circumstances
require
it.
These
charges,
if
established,
will
be
based
on
the
costs
of
operations
and
market
rates.
An
earlier
regulation
was
previously
located
in
the
Federal
Property
Management
Regulation
(
FPMR)
(
41
CFR
part
101
 
35,
subpart
101
 
35.7,
Network
Address
Registration)
and
expired
on
August
8,
2001.
Jurisdiction
of
the
Internet
GOV
(
dotgov
domain
was
delegated
to
GSA
in
1997
by
the
Federal
Networking
Council
with
guidance
in
the
form
of
Internet
Engineering
Task
Force
Informational
RFC
2146.
Since
then,
the
U.
S.
Government
use
of
the
Internet
has
evolved
and
is
rapidly
emerging
as
an
electronic
government
without
boundaries.
Federal
organizations
are
choosing
dot­
gov
domain
names
to
reflect
the
type
of
service
being
rendered
and
are
collaborating
to
form
portals
that
cross
boundaries
of
agencies,
departments,
and
other
U.
S.
government
entities.
GSA
reserves
the
right
to
make
exceptions
to
the
naming
conventions
described
in
this
subpart
on
a
case­
by­
case
basis
in
unique
and
compelling
cases.
In
addition,
there
is
increasing
interest
from
non­
Federal
U.
S.
government
entities,
such
as
State
and
VerDate
Jan<
31>
2003
15:
12
Mar
27,
2003
Jkt
200001
PO
00000
Frm
00045
Fmt
4700
Sfmt
4700
E:\
FR\
FM\
28MRR1.
SGM
28MRR1